76600 genotypes with 377399 annotations displayed
of selected term and subterms
|
Searched Term: mammalian phenotype
|
7a6ex/7a6ex
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased forebrain size
|
J:98216
|
embryonic lethality during organogenesis, complete penetrance
|
J:98216
|
exencephaly
|
J:98216
|
12aex/12aex
(involves: C3HeB/FeJ * C57BL/6J)
|
exencephaly
|
J:98216
|
perinatal lethality, complete penetrance
|
J:98216
|
31bex/31bex
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased forebrain size
|
J:98216
|
embryonic lethality during organogenesis, complete penetrance
|
J:98216
|
exencephaly
|
J:98216
|
38dlp/38dlp
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal lateral plate mesoderm morphology
|
J:98216
|
abnormal somite development
|
J:98216
|
embryonic growth arrest
|
J:98216
|
embryonic lethality during organogenesis, complete penetrance
|
J:98216
|
97c2/97c2
(involves: C3HeB/FeJ * C57BL/6J)
|
exencephaly
|
J:98216
|
open neural tube
|
J:98216
|
perinatal lethality, complete penetrance
|
J:98216
|
917M/917M
(involves: C3H * C57BL/6J)
|
decreased compact bone thickness
|
J:99483
|
917M/917M+
(C57BL/6-917M)
|
abnormal bone structure
|
J:99483,
J:132290
|
abnormal tibia morphology
|
J:99483
|
decreased bone mineral content
|
J:99483
|
decreased osteoblast proliferation
|
J:99483
|
0610009B22Riktm1b(EUCOMM)Hmgu/0610009B22Riktm1b(EUCOMM)Hmgu
(C57BL/6N-0610009B22Riktm1b(EUCOMM)Hmgu/BayMmucd)
|
abnormal retina inner nuclear layer morphology
|
J:211773
|
increased cornea thickness
|
J:211773
|
0610010K14Riktm1.1(KOMP)Vlcg/0610010K14Riktm1.1(KOMP)Vlcg
(C57BL/6N-0610010K14Riktm1.1(KOMP)Vlcg/MbpMmucd)
|
embryonic lethality prior to organogenesis
|
J:211773
|
embryonic lethality prior to tooth bud stage
|
J:211773
|
preweaning lethality, complete penetrance
|
J:211773
|
1110017D15Rikem1(IMPC)H/1110017D15Rikem1(IMPC)H
(C57BL/6N-1110017D15Rikem1(IMPC)H/H)
|
long tibia
|
J:211773
|
1110017D15Rikem1Osb/1110017D15Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
no abnormal phenotype detected
|
J:234235
|
1110032A03Riktm1.1(KOMP)Vlcg/1110032A03Riktm1.1(KOMP)Vlcg
(C57BL/6N-1110032A03Riktm1.1(KOMP)Vlcg/MbpMmucd)
|
hyperactivity
|
J:211773
|
1110059G10Riktm1a(KOMP)Wtsi/1110059G10Riktm1a(KOMP)Wtsi
(C57BL/6N-1110059G10Riktm1a(KOMP)Wtsi/Wtsi)
|
vertebral transformation
|
J:211773
|
1500009L16Rikem1(IMPC)Mbp/1500009L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-1500009L16Rikem1(IMPC)Mbp/Mmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
1600029I14Riktm1b(KOMP)Wtsi/1600029I14Riktm1b(KOMP)Wtsi
(C57BL/6N-1600029I14Riktm1b(KOMP)Wtsi/Ieg)
|
abnormal kidney morphology
|
J:211773
|
small epididymis
|
J:211773
|
1700001O22Rikem1(IMPC)J/1700001O22Rikem1(IMPC)J
(C57BL/6NJ-1700001O22Rikem1(IMPC)J/J)
|
abnormal lens morphology
|
J:211773
|
abnormal optic disk morphology
|
J:211773
|
abnormal retina blood vessel morphology
|
J:211773
|
abnormal retina vasculature morphology
|
J:211773
|
abnormal vitreous body morphology
|
J:211773
|
cataract
|
J:211773
|
fused cornea and lens
|
J:211773
|
iris synechia
|
J:211773
|
persistence of hyaloid vascular system
|
J:211773
|
1700001O22Rikem1Osb/1700001O22Rikem2Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
reproductive system phenotype
|
J:279039
|
1700003F12Riktm1.1(KOMP)Vlcg/1700003F12Riktm1.1(KOMP)Vlcg
(C57BL/6N-1700003F12Riktm1.1(KOMP)Vlcg/MbpMmucd)
|
abnormal embryo size
|
J:211773
|
abnormal heart morphology
|
J:211773
|
preweaning lethality, complete penetrance
|
J:211773
|
preweaning lethality, incomplete penetrance
|
J:211773
|
1700008O03Riktm1a(KOMP)Wtsi/1700008O03Riktm1a(KOMP)Wtsi
(C57BL/6N-1700008O03Riktm1a(KOMP)Wtsi/Wtsi)
|
abnormal hair growth
|
J:211773
|
increased hematocrit
|
J:211773
|
1700008P02Rikem1(IMPC)J/1700008P02Rikem1(IMPC)J
(C57BL/6NJ-1700008P02Rikem1(IMPC)J/Mmjax)
|
decreased heart weight
|
J:211773
|
decreased lean body mass
|
J:211773
|
increased total body fat amount
|
J:211773
|
1700010B08Rikem1Osb/1700010B08Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
reproductive system phenotype
|
J:279039
|
1700012B09Riktm1.1(KOMP)Wtsi/1700012B09Riktm1.1(KOMP)Wtsi
(C57BL/6N-1700012B09Riktm1.1(KOMP)Wtsi/Bay)
|
abnormal skin coloration
|
J:211773
|
1700012B09Riktm1.1Gos/1700012B09Riktm1.1Gos
(involves: 129 * CAST * C57BL/6 * CD-1 * SJL)
|
no abnormal phenotype detected
|
J:249115
|
1700013H16Rikem1Juhu/Y
(C57BL/6-1700013H16Rikem1Juhu)
|
growth/size/body region phenotype
|
J:282929
|
reproductive system phenotype
|
J:282929
|
1700013H16Rikem1Juhu/1700013H16Rikem1Juhu
(C57BL/6-1700013H16Rikem1Juhu)
|
reproductive system phenotype
|
J:282929
|
1700013H16Rikem11Juhu/Y
(C57BL/6-1700013H16Rikem11Juhu)
|
growth/size/body region phenotype
|
J:282929
|
reproductive system phenotype
|
J:282929
|
1700013H16Rikem11Juhu/1700013H16Rikem11Juhu
(C57BL/6-1700013H16Rikem11Juhu)
|
reproductive system phenotype
|
J:282929
|
1700016H13Rikem1(IMPC)Bay/1700016H13Rikem1(IMPC)Bay
(C57BL/6N-1700016H13Rikem1(IMPC)Bay/BayMmucd)
|
decreased body temperature
|
J:211773
|
1700016K19Riktm1.1(KOMP)Vlcg/1700016K19Riktm1.1(KOMP)Vlcg
(B6N(Cg)-1700016K19Riktm1.1(KOMP)Vlcg/J)
|
hyperactivity
|
J:211773
|
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93488
|
abnormal T cell activation
|
J:93488
|
decreased CD8-positive, alpha-beta T cell number
|
J:93488
|
decreased cytotoxic T cell cytolysis
|
J:93488
|
decreased dendritic cell number
|
J:93488
|
increased neutrophil cell number
|
J:194800
|
premature death
|
J:93488
|
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/J)
|
abnormal NK cell physiology
|
J:96123
|
abnormal NK T cell physiology
|
J:96123
|
decreased circulating interferon-gamma level
|
J:96123
|
decreased circulating interleukin-12 level
|
J:96123
|
decreased dendritic cell number
|
J:100867,
J:113232,
J:96123
|
decreased interferon-gamma secretion
|
J:96123
|
decreased interleukin-4 secretion
|
J:96123
|
decreased interleukin-12b secretion
|
J:125611
|
immune system phenotype
|
J:122114,
J:96123
|
impaired natural killer cell mediated cytotoxicity
|
J:125611
|
increased sensitivity to induced morbidity/mortality
|
J:113232
|
sepsis
|
J:113232
|
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/J)
|
abnormal NK cell physiology
|
J:96123
|
decreased circulating interferon-gamma level
|
J:96123
|
decreased circulating interleukin-12 level
|
J:96123
|
decreased dendritic cell number
|
J:96123
|
decreased interferon-gamma secretion
|
J:96123
|
immune system phenotype
|
J:96123
|
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(involves: C57BL/6 * FVB/N)
|
abnormal alveolar macrophage morphology
|
J:137452
|
decreased dendritic cell number
|
J:137452
|
decreased interferon-gamma secretion
|
J:137452
|
increased susceptibility to Orthomyxoviridae infection
|
J:137452
|
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/Jdk)
|
abnormal professional antigen presenting cell physiology
|
J:137009
|
cachexia
|
J:137009
|
decreased dendritic cell number
|
J:137009
|
decreased macrophage cell number
|
J:137009
|
decreased NK T cell number
|
J:137009
|
decreased susceptibility to autoimmune diabetes
|
J:137009
|
endocrine/exocrine gland phenotype
|
J:137009
|
increased interferon-gamma secretion
|
J:137009
|
increased tumor necrosis factor secretion
|
J:137009
|
insulitis
|
J:137009
|
premature death
|
J:137009
|
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(involves: FVB/N)
|
abnormal response to infection
|
J:189122
|
decreased gamma-delta T cell number
|
J:193548
|
decreased interleukin-17 secretion
|
J:193548
|
decreased leukocyte cell number
|
J:193548
|
decreased neutrophil cell number
|
J:193548
|
decreased physiological sensitivity to xenobiotic
|
J:193548
|
decreased susceptibility to bacterial infection
|
J:210086
|
decreased T cell number
|
J:193548
|
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan)
|
abnormal circulating cytokine level
|
J:194800
|
abnormal susceptibility to infection
|
J:194800
|
decreased dendritic cell number
|
J:194800
|
decreased neutrophil cell number
|
J:194800
|
impaired neutrophil recruitment
|
J:194800
|
increased monocyte cell number
|
J:194800
|
increased neutrophil cell number
|
J:194800
|
increased susceptibility to bacterial infection
|
J:194800
|
1700019D03Riktm1.1(NCOM)Mfgc/1700019D03Riktm1.1(NCOM)Mfgc
(C57BL/6N-1700019D03Riktm1.1(NCOM)Mfgc/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
enlarged lymph nodes
|
J:211773
|
thrombocytosis
|
J:211773
|
1700019N19Rikem1Osb/1700019N19Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
no abnormal phenotype detected
|
J:234235
|
1700021F07Rikem1(IMPC)Hmgu/1700021F07Rikem1(IMPC)Hmgu
(C57BL/6N-1700021F07Rikem1(IMPC)Hmgu/Ieg)
|
abnormal locomotor behavior
|
J:211773
|
1700025G04Rikem1(IMPC)Mbp/1700025G04Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700025G04Rikem1(IMPC)Mbp/Mmucd)
|
abnormal eye morphology
|
J:211773
|
abnormal heart morphology
|
J:211773
|
abnormal lymph node morphology
|
J:211773
|
abnormal spleen morphology
|
J:211773
|
abnormal vocalization
|
J:211773
|
anophthalmia
|
J:211773
|
enlarged heart
|
J:211773
|
enlarged lymph nodes
|
J:211773
|
enlarged spleen
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased mean corpuscular volume
|
J:211773
|
increased red blood cell distribution width
|
J:211773
|
1700028K03Rikem1Jzc/1700028K03Rikem1Jzc
(C57BL/6-1700028K03Rikem1Jzc)
|
abnormal double-strand DNA break repair
|
J:285969
|
abnormal female meiosis I arrest
|
J:285969
|
absent oocytes
|
J:285969
|
arrest of male meiosis
|
J:285969
|
azoospermia
|
J:285969
|
decreased oocyte number
|
J:285969
|
female infertility
|
J:285969
|
increased male germ cell apoptosis
|
J:285969
|
male infertility
|
J:285969
|
small ovary
|
J:285969
|
small testis
|
J:285969
|
1700029I15Riktm1.1(KOMP)Vlcg/1700029I15Riktm1.1(KOMP)Vlcg
(C57BL/6N-1700029I15Riktm1.1(KOMP)Vlcg/Mmucd)
|
abnormal skin morphology
|
J:211773
|
male infertility
|
J:211773
|
1700034E13Rikem1(IMPC)Mbp/1700034E13Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700034E13Rikem1(IMPC)Mbp/Mmucd)
|
abnormal eye morphology
|
J:211773
|
abnormal kidney morphology
|
J:211773
|
abnormal liver morphology
|
J:211773
|
abnormal lymph node morphology
|
J:211773
|
abnormal ovary morphology
|
J:211773
|
abnormal skin morphology
|
J:211773
|
abnormal spleen morphology
|
J:211773
|
abnormal stomach morphology
|
J:211773
|
anophthalmia
|
J:211773
|
enlarged liver
|
J:211773
|
enlarged lymph nodes
|
J:211773
|
enlarged seminal vesicle
|
J:211773
|
enlarged spleen
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
1700034J05Riktm1b(KOMP)Wtsi/1700034J05Riktm1b(KOMP)Wtsi
(involves: 129 * BALB/c * C57BL/6N)
|
no abnormal phenotype detected
|
J:234235
|
1700057G04Rikem1Kzt/1700057G04Rikem1Kzt
(involves: C57BL/6NJcl * DBA/2NJcl)
|
reproductive system phenotype
|
J:315008
|
1700067K01Riktm2a(KOMP)Wtsi/1700067K01Riktm2a(KOMP)Wtsi
(C57BL/6N-1700067K01Riktm2a(KOMP)Wtsi/Wtsi)
|
abnormal cervical rib
|
J:239583
|
abnormal coronary artery morphology
|
J:239583
|
abnormal forebrain morphology
|
J:239583
|
abnormal lung morphology
|
J:239583
|
abnormal Mullerian duct morphology
|
J:239583
|
abnormal umbilical artery morphology
|
J:239583
|
abnormal umbilical vein topology
|
J:239583
|
abnormal vertebral artery topology
|
J:239583
|
abnormal vitelline vein topology
|
J:239583
|
absent ductus venosus valve
|
J:239583
|
absent intrahepatic inferior vena cava segment
|
J:239583
|
absent segment of posterior cerebral artery
|
J:239583
|
arteriovenous malformation
|
J:239583
|
bifid ureter
|
J:239583
|
blood in lymph vessels
|
J:239583
|
dual inferior vena cava
|
J:239583
|
ductus venosus stenosis
|
J:239583
|
fusion of vertebral arches
|
J:239583
|
hepatic portal vein stenosis
|
J:239583
|
preweaning lethality, complete penetrance
|
J:211773
|
umbilical vein stenosis
|
J:239583
|
1700069L16Rikem1(IMPC)Mbp/1700069L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700069L16Rikem1(IMPC)Mbp/Mmucd)
|
hyperactivity
|
J:211773
|
1700086L19Riktm1b(EUCOMM)Wtsi/1700086L19Riktm1b(EUCOMM)Wtsi
(C57BL/6N-1700086L19Riktm1b(EUCOMM)Wtsi/Bay)
|
hyperactivity
|
J:211773
|
1700088E04Riktm1.1(KOMP)Vlcg/1700088E04Riktm1.1(KOMP)Vlcg
(B6N(Cg)-1700088E04Riktm1.1(KOMP)Vlcg/J)
|
abnormal retina morphology
|
J:211773
|
1700093K21Rikb2b3025Clo/1700093K21Rikb2b3025Clo
(C57BL/6J-1700093K21Rikb2b3025Clo)
|
abdominal situs ambiguus
|
J:175213
|
abnormal inferior vena cava morphology
|
J:175213
|
abnormal thoracic vertebrae morphology
|
J:175213
|
dextrocardia
|
J:175213
|
heterotaxia
|
J:175213
|
right-sided stomach
|
J:175213
|
1700093K21Rikem1(IMPC)J/1700093K21Rikem1(IMPC)J
(C57BL/6NJ-1700093K21Rikem1(IMPC)J/Mmjax)
|
hyperactivity
|
J:211773
|
1700093K21Riktm1Osb/1700093K21Riktm1Osb
(involves: C57BL/6NSlc)
|
no abnormal phenotype detected
|
J:234235
|
1700102P08Rikem1Feis/1700102P08Rikem1Feis
(C57BL/6-1700102P08Rikem1Feis)
|
arrest of male meiosis
|
J:301139
|
azoospermia
|
J:301139
|
increased male germ cell apoptosis
|
J:301139
|
male infertility
|
J:301139
|
reproductive system phenotype
|
J:301139
|
small epididymis
|
J:301139
|
small testis
|
J:301139
|
1700121C10Rikem1Smoc/1700121C10Rikem1Smoc
(involves: C57BL/6J)
|
reproductive system phenotype
|
J:288171
|
1700123O20Riktm1a(EUCOMM)Wtsi/1700123O20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd 1700123O20Riktm1a(EUCOMM)Wtsi/WtsiFlmg)
|
increased circulating iron level
|
J:211773
|
1700125H20Riktm1b(EUCOMM)Wtsi/1700125H20Riktm1b(EUCOMM)Wtsi
(involves: 129 * BALB/c * C57BL/6N)
|
no abnormal phenotype detected
|
J:234235
|
1700125H20Riktm1b(EUCOMM)Wtsi/1700125H20Riktm1b(EUCOMM)Wtsi
(C57BL/6N-1700125H20Riktm1b(EUCOMM)Wtsi/Bay)
|
increased circulating calcium level
|
J:211773
|
2210010C04Riktm1.1Satom/2210010C04Rik+
(B6(FVB)-2210010C04Riktm1.1Satom)
|
abnormal pancreas morphology
|
J:267764
|
acute pancreas inflammation
|
J:267764
|
chronic pancreas inflammation
|
J:267764
|
decreased circulating amylase level
|
J:267764
|
decreased pancreas weight
|
J:267764
|
decreased pancreatic acinar cell number
|
J:267764
|
enlarged pancreatic islets
|
J:267764
|
homeostasis/metabolism phenotype
|
J:267764
|
increased pancreas weight
|
J:267764
|
pancreas atrophy
|
J:267764
|
small pancreas
|
J:267764
|
2210010C04Riktm1.1Satom/2210010C04Riktm1.1Satom
(B6(FVB)-2210010C04Riktm1.1Satom)
|
decreased body size
|
J:267764
|
premature death
|
J:267764
|
2210010C04Riktm1b(KOMP)Wtsi/2210010C04Riktm1b(KOMP)Wtsi
(C57BL/6N-2210010C04Riktm1b(KOMP)Wtsi/Bay)
|
abnormal retina vasculature morphology
|
J:211773
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased prepulse inhibition
|
J:211773
|
hyperactivity
|
J:211773
|
2210010C04Riktm2.1Satom/2210010C04Rik+
(involves: C57BL/6 * FVB/N)
|
endocrine/exocrine gland phenotype
|
J:267764
|
2210408I21Riktm1b(EUCOMM)Wtsi/2210408I21Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2210408I21Riktm1b(EUCOMM)Wtsi/Tcp)
|
abnormal kidney morphology
|
J:211773
|
decreased bone mineral content
|
J:211773
|
decreased bone mineral density
|
J:211773
|
decreased lean body mass
|
J:211773
|
hydrometra
|
J:211773
|
impaired glucose tolerance
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
increased total body fat amount
|
J:211773
|
small superior vagus ganglion
|
J:211773
|
2300002M23Riktm1Lex/2300002M23Riktm1Lex
(B6;129S5-2300002M23Riktm1Lex/Mmucd)
|
decreased body weight
|
J:171883
|
decreased total body fat amount
|
J:171883
|
2310022B05Riktm1a(EUCOMM)Hmgu/2310022B05Riktm1a(EUCOMM)Hmgu
(C57BL/6N-2310022B05Riktm1a(EUCOMM)Hmgu/H)
|
increased B cell number
|
J:165965
|
increased grip strength
|
J:165965
|
increased leukocyte cell number
|
J:165965
|
2310039L15RikTg(Prnp-SNCA*A53T)23Mkle/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal motor capabilities/coordination/movement
|
J:77344
|
abnormal nervous system morphology
|
J:77344
|
abnormal neuron morphology
|
J:77344
|
abnormal spinal cord morphology
|
J:77344
|
astrocytosis
|
J:77344
|
ataxia
|
J:77344
|
bradykinesia
|
J:77344
|
dystonia
|
J:77344
|
impaired righting response
|
J:77344
|
neurodegeneration
|
J:77344
|
neuronal intranuclear inclusions
|
J:77344
|
paralysis
|
J:77344
|
premature death
|
J:77344
|
2310061I04Rikem1(IMPC)Bay/2310061I04Rikem1(IMPC)Bay
(C57BL/6N-2310061I04Rikem1(IMPC)Bay/BayMmucd)
|
preweaning lethality, incomplete penetrance
|
J:211773
|
2500002B13RikGt(Ayu21-T167)Imeg/2500002B13RikGt(Ayu21-T167)Imeg
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal mitochondrial physiology
|
J:311513
|
abnormal myocardial fiber physiology
|
J:311513
|
increased response of heart to induced stress
|
J:311513
|
2500002B13Riktm1(CAG-2500002B13Rik)Yo/2500002B13Rik+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased response of heart to induced stress
|
J:311513
|
increased mitochondrial number
|
J:311513
|
2510002D24Riktm1.1(KOMP)Vlcg/2510002D24Riktm1.1(KOMP)Vlcg
(C57BL/6N-2510002D24Riktm1.1(KOMP)Vlcg/MbpMmucd)
|
abnormal epididymis morphology
|
J:211773
|
abnormal testis morphology
|
J:211773
|
enlarged epididymis
|
J:211773
|
small testis
|
J:211773
|
2510002D24Riktm1.1(KOMP)Vlcg/2510002D24Riktm1.1(KOMP)Vlcg
(C57BL/6-2510002D24Riktm1.1(KOMP)Vlcg)
|
no abnormal phenotype detected
|
J:260409
|
2510009E07Rikem1(IMPC)Ccpcz/2510009E07Rikem1(IMPC)Ccpcz
(C57BL/6N-2510009E07Rikem1(IMPC)Ccpcz/Ccpcz)
|
abnormal adrenal gland morphology
|
J:211773
|
abnormal coat/ hair morphology
|
J:211773
|
abnormal heart morphology
|
J:211773
|
abnormal kidney morphology
|
J:211773
|
abnormal snout morphology
|
J:211773
|
enlarged adrenal glands
|
J:211773
|
enlarged heart
|
J:211773
|
enlarged kidney
|
J:211773
|
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor
(involves: 129S4/SvJaeSor)
|
abnormal frontal bone morphology
|
J:117491
|
abnormal neurocranium morphology
|
J:117491
|
abnormal skeleton morphology
|
J:117491
|
abnormal sternum morphology
|
J:117491
|
asymmetric sternocostal joints
|
J:117491
|
broad snout
|
J:117491
|
increased fibroblast cell migration
|
J:117491
|
prenatal lethality, incomplete penetrance
|
J:117491
|
short maxilla
|
J:117491
|
short nasal bone
|
J:117491
|
short premaxilla
|
J:117491
|
short snout
|
J:117491
|
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor Pdgfratm1Sor/Pdgfra+
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal ovary morphology
|
J:142042
|
abnormal vascular smooth muscle morphology
|
J:142042
|
anovulation
|
J:142042
|
decreased circulating estradiol level
|
J:142042
|
decreased corpora lutea number
|
J:142042
|
decreased tertiary ovarian follicle number
|
J:142042
|
decreased theca cell number
|
J:142042
|
female infertility
|
J:142042
|
small ovary
|
J:142042
|
uterus hypoplasia
|
J:142042
|
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor Pdgfratm2Sor/Pdgfra+
(involves: 129S4/SvJaeSor)
|
abnormal frontal bone morphology
|
J:117491
|
abnormal skeleton morphology
|
J:117491
|
broad snout
|
J:117491
|
short maxilla
|
J:117491
|
short nasal bone
|
J:117491
|
short premaxilla
|
J:117491
|
short snout
|
J:117491
|
2610008E11Rikem1(IMPC)Mbp/2610008E11Rikem1(IMPC)Mbp
(C57BL/6N-2610008E11Rikem1(IMPC)Mbp/MbpMmucd)
|
abnormal heart morphology
|
J:211773
|
abnormal kidney morphology
|
J:211773
|
abnormal liver morphology
|
J:211773
|
abnormal skin morphology
|
J:211773
|
enlarged kidney
|
J:211773
|
small heart
|
J:211773
|
small liver
|
J:211773
|
2610318N02Riktm1b(EUCOMM)Wtsi/2610318N02Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2610318N02Riktm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:211773
|
2610528A11Riktm1Lex/2610528A11Riktm1Lex
(B6;129S5-2610528A11Riktm1Lex/Mmucd)
|
increased IgG2a level
|
J:171883
|
2700049A03Riktm1.1Arte/2700049A03Riktm1.1Arte Tg(Prrx1-cre)1Cjt/0
(involves: C57BL/6J * C57BL/6NTac * SJL/J)
|
abnormal carpal bone morphology
|
J:175541
|
abnormal cell morphology
|
J:175541
|
abnormal digit development
|
J:175541
|
abnormal digit morphology
|
J:175541
|
abnormal embryonic autopod plate morphology
|
J:175541
|
abnormal endochondral bone ossification
|
J:175541
|
abnormal limb mesenchyme morphology
|
J:175541
|
abnormal long bone epiphyseal plate morphology
|
J:175541
|
abnormal skeleton development
|
J:175541
|
brachydactyly
|
J:175541
|
decreased fibroblast cell migration
|
J:175541
|
decreased length of long bones
|
J:175541
|
polydactyly
|
J:175541
|
polysyndactyly
|
J:175541
|
short femur
|
J:175541
|
short fibula
|
J:175541
|
short humerus
|
J:175541
|
short limbs
|
J:175541
|
short radius
|
J:175541
|
short scapula
|
J:175541
|
short tibia
|
J:175541
|
short ulna
|
J:175541
|
2700049A03Riktm1.2Arte/2700049A03Riktm1.2Arte
(either: (involves: C57BL/6NTac) or (involves: C57BL/6NTac * CD-1))
|
abnormal centrosome morphology
|
J:175541
|
abnormal direction of heart looping
|
J:175541
|
abnormal lateral nasal prominence morphology
|
J:175541
|
abnormal left-right axis patterning
|
J:175541
|
abnormal medial nasal prominence morphology
|
J:175541
|
abnormal neural tube morphology
|
J:175541
|
absent embryonic cilia
|
J:175541
|
embryonic growth arrest
|
J:175541
|
embryonic lethality during organogenesis, complete penetrance
|
J:175541
|
hemorrhage
|
J:175541
|
narrow head
|
J:175541
|
pericardial edema
|
J:175541
|
2700049A03Riktm1Blnw/2700049A03Riktm1Blnw
(Not Specified)
|
abnormal cell morphology
|
J:220629
|
2700054A10Rikem2(IMPC)Mbp/2700054A10Rikem2(IMPC)Mbp
(C57BL/6NCrl-2700054A10Rikem2(IMPC)Mbp/Mmucd)
|
abnormal eye morphology
|
J:211773
|
anophthalmia
|
J:211773
|
hydrometra
|
J:211773
|
small superior vagus ganglion
|
J:211773
|
2700097O09Riktm1.1(KOMP)Vlcg/2700097O09Riktm1.1(KOMP)Vlcg
(C57BL/6N-2700097O09Riktm1.1(KOMP)Vlcg/MbpMmucd)
|
abnormal epididymis morphology
|
J:211773
|
abnormal liver morphology
|
J:211773
|
enlarged epididymis
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
limb grasping
|
J:211773
|
preweaning lethality, incomplete penetrance
|
J:211773
|
2810408A11Riktm1a(EUCOMM)Wtsi/2810408A11Riktm1a(EUCOMM)Wtsi
(C57BL/6N-2810408A11Riktm1a(EUCOMM)Wtsi/H)
|
abnormal bone mineralization
|
J:165965
|
abnormal bone structure
|
J:165965
|
decreased NK cell number
|
J:165965
|
increased body weight
|
J:165965
|
increased CD4-positive, alpha beta T cell number
|
J:165965
|
increased heart weight
|
J:165965
|
increased NK cell number
|
J:165965
|
limb grasping
|
J:165965
|
2900026A02Riktm1a(EUCOMM)Hmgu/2900026A02Riktm1a(EUCOMM)Hmgu
(C57BL/6N-2900026A02Riktm1a(EUCOMM)Hmgu/Ics)
|
abnormal eye morphology
|
J:165965
|
abnormal retina morphology
|
J:165965
|
2900092C05Rikem1Osb/2900092C05Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
no abnormal phenotype detected
|
J:234235
|
3425401B19Rikem2(IMPC)Ccpcz/3425401B19Rikem2(IMPC)Ccpcz
(C57BL/6NCrl-3425401B19Rikem2(IMPC)Ccpcz/Ph)
|
decreased circulating potassium level
|
J:211773
|
decreased grip strength
|
J:211773
|
increased effector memory T-helper cell number
|
J:211773
|
increased eosinophil cell number
|
J:211773
|
3830406C13Riktm1b(KOMP)Wtsi/3830406C13Riktm1b(KOMP)Wtsi
(C57BL/6N-3830406C13Riktm1b(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
4833411C07Rikem1Cecad/4833411C07Rikem1Cecad
(C57BL/6N-4833411C07Rikem1Cecad)
|
impaired glucose tolerance
|
J:285483
|
increased circulating glucose level
|
J:285483
|
insulin resistance
|
J:285483
|
4833420G17Rikem1(IMPC)Mbp/4833420G17Rikem1(IMPC)Mbp
(C57BL/6NCrl-4833420G17Rikem1(IMPC)Mbp/Mmucd)
|
abnormal eye morphology
|
J:211773
|
abnormal heart morphology
|
J:211773
|
decreased body length
|
J:211773
|
enlarged heart
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
4921507P07Rikem1Osb/4921507P07Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
reproductive system phenotype
|
J:293870
|
4921509C19Riktm1.1(KOMP)Vlcg/4921509C19Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4921509C19Riktm1.1(KOMP)Vlcg/J)
|
increased heart weight
|
J:211773
|
4921536K21Riktm1a(KOMP)Wtsi/4921536K21Riktm1a(KOMP)Wtsi
(C57BL/6N-4921536K21Riktm1a(KOMP)Wtsi/Wtsi)
|
decreased total body fat amount
|
J:211773
|
increased grip strength
|
J:211773
|
4921539E11Rikem1Osb/4921539E11Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
no abnormal phenotype detected
|
J:315008
|
4930402F06Rikem1Osb/4930402F06Rikem1Osb 4930568D16Rikem1Osb/4930568D16Rikem1Osb Glt6d1em2Osb/Glt6d1em2Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
reproductive system phenotype
|
J:296968
|
4930404H24Riktm1a(KOMP)Wtsi/4930404H24Riktm1a(KOMP)Wtsi
(C57BL/6N-4930404H24Riktm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
increased mean platelet volume
|
J:211773
|
4930447C04Rikem1(IMPC)Bay/4930447C04Rikem1(IMPC)Bay
(C57BL/6N-4930447C04Rikem1(IMPC)Bay/BayMmucd)
|
decreased grip strength
|
J:211773
|
female infertility
|
J:211773
|
male infertility
|
J:211773
|
4930447C04Rikem1Amp/4930447C04Rikem1Amp
(involves: C57BL/6J * CBA/J)
|
abnormal chiasmata formation
|
J:238491
|
abnormal chromosomal synapsis
|
J:238491
|
abnormal male meiosis
|
J:238491
|
abnormal meiosis
|
J:238491
|
abnormal oogenesis
|
J:238491
|
abnormal ovarian follicle number
|
J:238491
|
abnormal ovary morphology
|
J:238491
|
abnormal seminiferous tubule morphology
|
J:238491
|
abnormal X-Y chromosome synapsis during male meiosis
|
J:238491
|
absent oocytes
|
J:238491
|
arrest of male meiosis
|
J:238491
|
azoospermia
|
J:238491
|
female infertility
|
J:238491
|
increased male germ cell apoptosis
|
J:238491
|
male infertility
|
J:238491
|
small testis
|
J:238491
|
4930447F04Rikem1Utr/Y
(C57BL/6J-4930447F04Rikem1Utr)
|
reproductive system phenotype
|
J:292550
|
4930451I11Rikem1Osb/4930451I11Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
impaired fertilization
|
J:287619
|
reduced male fertility
|
J:287619
|
reproductive system phenotype
|
J:287619
|
4930451I11Rikem2Osb/4930451I11Rikem2Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
impaired fertilization
|
J:287619
|
4930451I11Riktm1.1(KOMP)Wtsi/4930451I11Riktm1.1(KOMP)Wtsi
(C57BL/6N-4930451I11Riktm1.1(KOMP)Wtsi/Bay)
|
female infertility
|
J:211773
|
male infertility
|
J:211773
|
4930453N24Rikdin/4930453N24Rikdin
(B6C3Fe a/a-4930453N24Rikdin/J)
|
abnormal coat/hair pigmentation
|
J:32738
|
abnormal dentin development
|
J:32738
|
abnormal dentin morphology
|
J:32738
|
abnormal incisor morphology
|
J:32738
|
failure of tooth eruption
|
J:32738
|
irregular coat pigmentation
|
J:32738
|
malocclusion
|
J:32738
|
postnatal growth retardation
|
J:32738
|
premature death
|
J:32738
|
small ears
|
J:32738
|
4930505A04Riktm1b(KOMP)Wtsi/4930505A04Riktm1b(KOMP)Wtsi
(C57BL/6N-4930505A04Riktm1b(KOMP)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
tremors
|
J:211773
|
4930522H14Rikem1Kher/4930522H14Rikem1Kher
(involves: C57BL/6 * DBA/2)
|
reproductive system phenotype
|
J:323102
|
4930522H14Rikem1Osb/4930522H14Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
no abnormal phenotype detected
|
J:234235
|
4930524B15Rikem1(IMPC)Mbp/4930524B15Rikem1(IMPC)Mbp
(C57BL/6NCrl-4930524B15Rikem1(IMPC)Mbp/Mmucd)
|
abnormal gallbladder morphology
|
J:211773
|
4930524B15Rikem1Qsh/4930524B15Rikem1Qsh
(Not Specified)
|
growth/size/body region phenotype
|
J:308296
|
mortality/aging
|
J:308296
|
reproductive system phenotype
|
J:308296
|
4930563E22Riktm1.1(KOMP)Vlcg/4930563E22Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4930563E22Riktm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
4930568D16Rikem1Osb/4930568D16Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
reproductive system phenotype
|
J:296968
|
4930568D16Rikem1Osb/4930568D16Rikem1Osb Glt6d1em2Osb/Glt6d1em2Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
reproductive system phenotype
|
J:296968
|
4930579G24Rikem1Qsh/4930579G24Rikem1Qsh
(C57BL/6-4930579G24Rikem1Qsh)
|
behavior/neurological phenotype
|
J:307600
|
growth/size/body region phenotype
|
J:307600
|
reproductive system phenotype
|
J:307600
|
4930590J08Riktm1a(EUCOMM)Wtsi/4930590J08Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4930590J08Riktm1a(EUCOMM)Wtsi/Wtsi)
|
male infertility
|
J:211773
|
4930591A17Riktm1a(KOMP)Wtsi/4930591A17Riktm1a(KOMP)Wtsi
(C57BL/6N-4930591A17Riktm1a(KOMP)Wtsi/Wtsi)
|
decreased total body fat amount
|
J:211773
|
increased lean body mass
|
J:211773
|
increased red blood cell distribution width
|
J:211773
|
4931406B18Rikem1Osb/4931406B18Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
no abnormal phenotype detected
|
J:234235
|
4931406C07Riktm1b(EUCOMM)Wtsi/4931406C07Riktm1b(EUCOMM)Wtsi
(C57BL/6N-4931406C07Riktm1b(EUCOMM)Wtsi/BayMmucd)
|
abnormal retina inner nuclear layer morphology
|
J:211773
|
increased heart rate variability
|
J:211773
|
4931414P19Rikem1Lych/4931414P19Rikem1Lych
(involves: C57BL/6)
|
decreased activity of thyroid gland
|
J:275266
|
decreased thyroxine level
|
J:275266
|
decreased triiodothyronine level
|
J:275266
|
increased circulating thyroid-stimulating hormone level
|
J:275266
|
4931422A03Riktm1b(EUCOMM)Wtsi/4931422A03Riktm1b(EUCOMM)Wtsi
(C57BL/6N-4931422A03Riktm1b(EUCOMM)Wtsi/Bay)
|
increased body length
|
J:211773
|
4931429L15Riktm1a(EUCOMM)Wtsi/4931429L15Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4931429L15Riktm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
4932438H23Riktm1a(EUCOMM)Wtsi/4932438H23Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4932438H23Riktm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal vertebral arch morphology
|
J:211773
|
4933402J07Rikem1(IMPC)J/4933402J07Rikem1(IMPC)J
(C57BL/6NJ-4933402J07Rikem1(IMPC)J/Mmjax)
|
improved glucose tolerance
|
J:211773
|
4933402N03Riktm2a(KOMP)Wtsi/4933402N03Riktm2a(KOMP)Wtsi
(C57BL/6N-4933402N03Riktm2a(KOMP)Wtsi/Wtsi)
|
abnormal cranium morphology
|
J:211773
|
abnormal hair growth
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased red blood cell distribution width
|
J:211773
|
4933417A18Rikem1Osb/4933417A18Rikem1Osb
(involves: C57BL/6NJcl * DBA/2NJcl)
|
no abnormal phenotype detected
|
J:234235
|
4933427D14Riktm1.1(KOMP)Vlcg/4933427D14Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4933427D14Riktm1.1(KOMP)Vlcg/J)
|
abnormal embryo turning
|
J:279207
|
decreased embryo size
|
J:279207
|
embryonic growth retardation
|
J:279207
|
embryonic lethality prior to organogenesis
|
J:279207
|
embryonic lethality, complete penetrance
|
J:279207
|
4933428G20Riktm1.1(KOMP)Vlcg/4933428G20Riktm1.1(KOMP)Vlcg
(C57BL/6N-4933428G20Riktm1.1(KOMP)Vlcg/MbpMmucd)
|
increased bone mineral content
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
4933430I17Riktm1a(EUCOMM)Wtsi/4933430I17Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1a(EUCOMM)Wtsi/Ics)
|
abnormal pancreas morphology
|
J:211773
|
increased mean corpuscular volume
|
J:211773
|
4933430I17Riktm1b(EUCOMM)Wtsi/4933430I17Riktm1b(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1b(EUCOMM)Wtsi/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
short tibia
|
J:211773
|
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Rik+
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal aortic valve cusp morphology
|
J:239583
|
abnormal atrioventricular cushion morphology
|
J:239583
|
abnormal brain internal capsule morphology
|
J:239583
|
abnormal cerebral cortex morphology
|
J:239583
|
abnormal ductus venosus valve morphology
|
J:239583
|
abnormal ductus venosus valve topology
|
J:239583
|
abnormal dural venous sinus morphology
|
J:239583
|
abnormal eye muscle morphology
|
J:239583
|
abnormal forebrain morphology
|
J:239583
|
abnormal heart atrium morphology
|
J:239583
|
abnormal heart position or orientation
|
J:239583
|
abnormal heart right atrium morphology
|
J:239583
|
abnormal hindbrain morphology
|
J:239583
|
abnormal hypoglossal nerve topology
|
J:239583
|
abnormal inferior vena cava valve morphology
|
J:239583
|
abnormal infrahyoid muscle connection
|
J:239583
|
abnormal interatrial septum morphology
|
J:239583
|
abnormal larynx morphology
|
J:239583
|
abnormal lens morphology
|
J:239583
|
abnormal Mullerian duct morphology
|
J:239583
|
abnormal pectinate muscle morphology
|
J:239583
|
abnormal pineal gland morphology
|
J:239583
|
abnormal pulmonary valve cusp morphology
|
J:239583
|
abnormal vertebral arch morphology
|
J:239583
|
abnormal vertebral artery topology
|
J:239583
|
abnormal vertebral body morphology
|
J:239583
|
abnormal vitelline vein connection
|
J:239583
|
abnormal Wolffian duct connection
|
J:239583
|
absent costovertebral joint
|
J:239583
|
absent ductus venosus valve
|
J:239583
|
absent hypoglossal canal
|
J:239583
|
absent hypoglossal nerve
|
J:239583
|
absent lobe of thyroid gland
|
J:239583
|
absent segment of posterior cerebral artery
|
J:239583
|
absent vertebral arch
|
J:239583
|
anal atresia
|
J:239583
|
arteriovenous malformation
|
J:239583
|
blood in lymph vessels
|
J:239583
|
dilated liver sinusoidal space
|
J:239583
|
dorsal root ganglion hypoplasia
|
J:239583
|
double ureter
|
J:239583
|
embryo cyst
|
J:239583
|
enlarged lymphatic vessel
|
J:239583
|
fused dorsal root ganglion
|
J:239583
|
fusion of vertebral arches
|
J:239583
|
herniated liver
|
J:239583
|
heterochrony
|
J:239583
|
intestinal/bowel diverticulum
|
J:239583
|
muscular ventricular septal defect
|
J:239583
|
overriding aortic valve
|
J:239583
|
perimembraneous ventricular septal defect
|
J:239583
|
persistent trigeminal artery
|
J:239583
|
preweaning lethality, complete penetrance
|
J:211773
|
reduced sympathetic cervical ganglion size
|
J:239583
|
retro-esophageal left subclavian artery
|
J:239583
|
retroesophageal right subclavian artery
|
J:239583
|
right aortic arch
|
J:239583
|
small superior cervical ganglion
|
J:239583
|
subcutaneous edema
|
J:239583
|
thin hypoglossal nerve
|
J:239583
|
urinary bladder hypoplasia
|
J:239583
|
4933436I01Rikem1Utr/Y
(C57BL/6J-4933436I01Rikem1Utr)
|
reproductive system phenotype
|
J:292550
|
5430431A17Rikem1Doca/5430431A17Rikem1Doca
(C57BL/6-5430431A17Rikem1Doca)
|
abnormal skeletal muscle fiber morphology
|
J:266332
|
decreased heart left ventricle size
|
J:266332
|
decreased heart right ventricle size
|
J:266332
|
heart hyperplasia
|
J:266332
|
increased heart weight
|
J:266332
|
increased systemic arterial diastolic blood pressure
|
J:266332
|
increased systemic arterial systolic blood pressure
|
J:266332
|
premature death
|
J:266332
|
thick ventricular wall
|
J:266332
|
6030468B19Riktm1Lex/6030468B19Riktm1Lex
(B6;129S5-6030468B19Riktm1Lex/Mmucd)
|
no abnormal phenotype detected
|
J:171883
|
6430548M08Rikem1(IMPC)Mbp/6430548M08Rikem1(IMPC)Mbp
(C57BL/6N-6430548M08Rikem1(IMPC)Mbp/MbpMmucd)
|
abnormal kidney morphology
|
J:211773
|
abnormal lymph node morphology
|
J:211773
|
enlarged kidney
|
J:211773
|
enlarged lymph nodes
|
J:211773
|
7630403G23RikTg(Th-cre)1Tmd/7630403G23Rik+ Trpc5tm1.1Mfre/Trpc5tm1.1Mfre
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6N * SJL)
|
abnormal action potential
|
J:277600
|
abnormal estrus
|
J:277600
|
decreased circulating luteinizing hormone level
|
J:277600
|
decreased circulating prolactin level
|
J:277600
|
decreased litter size
|
J:277600
|
decreased ovulation rate
|
J:277600
|
prolonged diestrus
|
J:277600
|
prolonged estrous cycle
|
J:277600
|
reduced female fertility
|
J:277600
|
9030622O22Rikem1Eem/9030622O22Rik+ Foxa2tm1.1Khk/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
abnormal respiratory mucosa goblet cell morphology
|
J:284174
|
respiratory system inflammation
|
J:284174
|
9030622O22Rikem1Eem/9030622O22Rikem1Eem
(involves: C57BL/6 * CD-1)
|
abnormal respiratory mucosa goblet cell morphology
|
J:284174
|
increased susceptibility to injury
|
J:284174
|
lung inflammation
|
J:284174
|
9430015G10Riktm1Lex/9430015G10Riktm1Lex
(B6;129S5-9430015G10Riktm1Lex/Mmucd)
|
decreased CD4-positive, alpha beta T cell number
|
J:171883
|
increased B cell number
|
J:171883
|
increased thermal nociceptive threshold
|
J:171883
|
9530003J23Riktm1(KOMP)Vlcg/9530003J23Riktm1(KOMP)Vlcg
(C57BL/6N-9530003J23Riktm1(KOMP)Vlcg/MbpMmucd)
|
decreased bone mineral density
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
9630013A20Rikem1Qrlu/9630013A20Rikem1Qrlu
(Not Specified)
|
abnormal oligodendrocyte morphology
|
J:256017
|
dysmyelination
|
J:256017
|
nervous system phenotype
|
J:256017
|
9930012K11Riktm2b(EUCOMM)Hmgu/9930012K11Riktm2b(EUCOMM)Hmgu
(C57BL/6N-9930012K11Riktm2b(EUCOMM)Hmgu/Bay)
|
abnormal skin coloration
|
J:211773
|
increased total retina thickness
|
J:211773
|
a/a
(involves: SM/J)
|
endocrine/exocrine gland phenotype
|
J:19308
|
a/a
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:36414
|
darkened coat color
|
J:36414
|
a/a Bloc1s6pa/Bloc1s6pa
(involves: C57BL/6J)
|
abnormal retina melanin granule morphology
|
J:5346
|
a/a Corintm1Bamo/Corintm1Bamo
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
integument phenotype
|
J:130426
|
a/a DctSlt-lt/Dct+
(involves: C3H/HeJ)
|
diluted coat color
|
J:27515
|
a/a DctSlt-lt/DctSlt-lt
(involves: C3H/HeJ)
|
diluted coat color
|
J:27515
|
a/a Hps6ru-5J/Hps6ru-5J Lystbg/Lystbg
(involves: C3H/Rl * C57BL/6J)
|
abnormal coat/hair pigmentation
|
J:26546
|
abnormal eye pigmentation
|
J:26546
|
decreased eye pigmentation
|
J:26546
|
diluted coat color
|
J:26546
|
a/a Hps6ru/Hps6ru
(B6.Cg-Hps6ru)
|
abnormal coat/hair pigmentation
|
J:6064
|
abnormal kidney physiology
|
J:6422
|
abnormal lateral geniculate nucleus morphology
|
J:6064
|
abnormal retina ganglion cell morphology
|
J:6064
|
decreased platelet ADP level
|
J:7327
|
decreased platelet ATP level
|
J:7327
|
decreased platelet dense granule number
|
J:7327
|
decreased platelet serotonin level
|
J:7327,
J:29748
|
decreased susceptibility to atherosclerosis
|
J:29748
|
increased bleeding time
|
J:7327
|
a/a Hps6ru/Hps6ru
(Not Specified)
|
abnormal choroid pigmentation
|
J:81444
|
abnormal eye pigmentation
|
J:81444,
J:13122
|
abnormal iris pigmentation
|
J:13122
|
decreased eye pigmentation
|
J:13122
|
diluted coat color
|
J:13122
|
hypopigmentation
|
J:12970
|
a/a Hps6ru/Hps6ru
(involves: C57BL/6J)
|
abnormal eye pigmentation
|
J:5346
|
abnormal melanogenesis
|
J:5346
|
abnormal melanosome morphology
|
J:5346
|
a/a Hps6ru/Hps6ru Lystbg/Lystbg
(involves: C3H/Rl * C57BL/6J)
|
abnormal melanogenesis
|
J:5346
|
abnormal melanosome morphology
|
J:5346
|
abnormal retina melanin granule morphology
|
J:5346
|
a/a In(11Trp53;11Wnt3)8Brd/+
(involves: 129S7/SvEvBrd * C57BL/6Brd * C57BL/6J)
|
abnormal tail pigmentation
|
J:56548
|
a/a KitW-2J/Kit+
(involves: C57BL/6J)
|
white spotting
|
J:192797
|
a/a Lystbg/Lystbg
(involves: C3H/Rl * C57BL/6J)
|
abnormal choroid melanin granule morphology
|
J:5346
|
abnormal retina melanin granule morphology
|
J:5346
|
a/a Lystbg/Lystbg Oca2p-J/Oca2p-J
(involves: C3H/HeJ * C3H/Rl * C57BL/6J)
|
abnormal choroid melanin granule morphology
|
J:5346
|
abnormal melanosome morphology
|
J:5346
|
a/a Lystbg/Lystbg Tyrc/Tyrc
(involves: C3H/Rl * C57BL/6J)
|
abnormal choroid melanin granule morphology
|
J:5346
|
abnormal melanogenesis
|
J:5346
|
abnormal melanosome morphology
|
J:5346
|
abnormal retina melanin granule morphology
|
J:5346
|
a/a Lystbg/Lystbg Tyrp1b/Tyrp1b
(involves: C3H/Rl * C57BL/6J)
|
abnormal choroid melanin granule morphology
|
J:5346
|
abnormal retina melanin granule morphology
|
J:5346
|
a/a Mc1re/Mc1re Pomctm1Sora/Pomctm1Sora Tg(MC1R)1Jkn/?
(involves: 129S6/SvEvTac * C57BL/6Ha)
|
abnormal hair follicle pheomelanosome pheomelanin content
|
J:129904
|
yellow coat color
|
J:129904
|
a/a Mlphln/Mlphln
(involves: C57BL/J * C57BR)
|
abnormal choroid melanin granule morphology
|
J:5346
|
abnormal hair follicle melanin granule distribution
|
J:5346
|
a/a Mlphln/Mlphln
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:12970
|
abnormal hair follicle melanocyte morphology
|
J:12970
|
abnormal hair shaft melanin granule distribution
|
J:12970
|
diluted coat color
|
J:12970
|
a/a Mlphln/Mlphln Tyrp1b/Tyrp1b
(C57L/J)
|
abnormal coat/hair pigmentation
|
J:5095
|
abnormal melanocyte morphology
|
J:5095
|
diluted coat color
|
J:5095
|
a/a Mregdsu/Mregdsu Hps6ru/Hps6ru
(involves: C57BL/6J)
|
diluted coat color
|
J:29467
|
phenotypic reversion
|
J:29467
|
a/a Mssq1KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq3KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq4KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq5C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq6C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq6KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq7KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq8C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq9C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq10KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq11KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq12KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq13C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq13KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq14KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq15C57BL/6JJcl/Mssq15KK/TaJcl
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Mssq16KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
a/a Myo5ad/Myo5a+ Oca2p/Oca2+ Tyrp1B-lt/Tyrp1+
(involves: C58 * CT/Ch)
|
diluted coat color
|
J:13094
|
a/a Myo5ad/Myo5ad
(involves: DBA/2J)
|
abnormal choroid melanin granule morphology
|
J:5346
|
abnormal hair follicle melanin granule distribution
|
J:5346
|
a/a Myo5ad/Myo5ad
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:12958
|
abnormal eye pigmentation
|
J:12958
|
abnormal hair shaft melanin granule distribution
|
J:12958
|
abnormal hair shaft morphology
|
J:12958
|
abnormal melanocyte morphology
|
J:12970
|
diluted coat color
|
J:12958
|
a/a Oca2p-J/Oca2p-J
(involves: C3H/HeJ)
|
abnormal choroid melanin granule morphology
|
J:5346
|
abnormal melanogenesis
|
J:5346
|
abnormal melanosome morphology
|
J:5346
|
a/a Oca2p/Oca2p
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:12958,
J:78801
|
abnormal hair follicle melanin granule distribution
|
J:12958
|
abnormal hair follicle melanin granule morphology
|
J:12958
|
abnormal hair follicle melanin granule shape
|
J:12958
|
abnormal hair follicle melanocyte morphology
|
J:78801
|
decreased ear pigmentation
|
J:36414,
J:78801
|
decreased eye pigmentation
|
J:78801
|
decreased skin pigmentation
|
J:36414
|
decreased tail pigmentation
|
J:78801
|
a/a Pax3Sp-1H/Pax3Sp-1H
(involves: 101/H * C3H/HeH * C57BL/6)
|
abnormal cerebral cortex morphology
|
J:19818
|
abnormal lateral ventricle morphology
|
J:19818
|
absent choroid plexus
|
J:19818
|
absent olfactory bulb
|
J:19818
|
exencephaly
|
J:19818
|
incomplete rostral neuropore closure
|
J:19818
|
a/a Rab27aash/Rab27aash
(involves: C3H/HeSnJ * C57BL/6J)
|
decreased platelet serotonin level
|
J:77395
|
hematopoietic system phenotype
|
J:77395
|
increased bleeding time
|
J:77395
|
a/a Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK)
|
behavior/neurological phenotype
|
J:168271
|
decreased body weight
|
J:168271
|
decreased circulating glucose level
|
J:168271
|
decreased gonadal fat pad weight
|
J:168271
|
decreased liver weight
|
J:168271
|
improved glucose tolerance
|
J:168271
|
a/a Tyrc-i/Tyrc-i
(involves: STOCK Tyrc-r)
|
abnormal coat/hair pigmentation
|
J:83666
|
diluted coat color
|
J:83666
|
a/a Tyrc/Tyrc
(involves: C57BL/6J)
|
abnormal melanogenesis
|
J:5346
|
a/a Tyrc/Tyrem2Ove
(involves: C57BL/6 * FVB)
|
decreased eye pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
a/a Tyrc/Tyrem4Ove
(involves: C57BL/6 * FVB)
|
abnormal eye pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
a/a Tyrc/Tyrem9Ove
(involves: C57BL/6 * FVB)
|
diluted coat color
|
J:94077
|
a/a Tyrc/Tyrem14Ove
(involves: C57BL/6 * FVB)
|
diluted coat color
|
J:94077
|
a/a Tyrem2Ove/Tyrem2Ove
(involves: C57BL/6 * FVB)
|
abnormal eye pigmentation
|
J:94077
|
abnormal tail pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
a/a Tyrem4Ove/Tyrem4Ove
(involves: C57BL/6 * FVB)
|
abnormal eye pigmentation
|
J:94077
|
decreased tail pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
a/a Tyrem14Ove/Tyrem14Ove
(involves: C57BL/6 * FVB)
|
diluted coat color
|
J:94077
|
a/a Tyrp1B-lt/Tyrp1+
(Not Specified)
|
abnormal dorsoventral coat patterning
|
J:13094
|
abnormal hair shaft melanin granule distribution
|
J:13094
|
abnormal hair shaft melanin granule morphology
|
J:13094
|
reduced hair shaft melanin granule number
|
J:13094
|
a/a Tyrp1B-lt/Tyrp1B-lt
(Not Specified)
|
abnormal dorsoventral coat patterning
|
J:13094
|
abnormal hair follicle melanin granule morphology
|
J:13094
|
abnormal hair shaft melanin granule distribution
|
J:13094
|
abnormal hair shaft melanin granule morphology
|
J:13094
|
enlarged hair follicle melanin granules
|
J:13094
|
reduced hair shaft melanin granule number
|
J:13094
|
a/a Tyrp1b/Tyrp1b
(involves: C57BL/6J)
|
abnormal melanosome morphology
|
J:5346
|
a/a Tyrp1b/Tyrp1b
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:12970
|
abnormal eye pigmentation
|
J:12970
|
abnormal melanocyte morphology
|
J:12970
|
a/a Tyrp1b/Tyrp1b wad/wad
(Not Specified)
|
diluted coat color
|
J:162146
|
a/a Tyrp1b/Tyrp1b wad/wad+
(Not Specified)
|
diluted coat color
|
J:162146
|
a/a U/U
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:78801
|
darkened coat color
|
J:78801
|
a/a Zc3h4KK/Zc3h4KK
(involves: C57BL/6J * KK-Ay)
|
increased body weight
|
J:48704
|
a/A Mc1re/Mc1re Pomctm1Sora/Pomctm1Sora Tg(MC1R)1Jkn/?
(involves: 129S6/SvEvTac * C57BL/6Ha)
|
abnormal hair follicle pheomelanosome pheomelanin content
|
J:129904
|
yellow coat color
|
J:129904
|
a/A Pomctm1Sora/Pomctm1Sora
(involves: 129S6/SvEvTac)
|
abnormal hair follicle pheomelanosome pheomelanin content
|
J:129904
|
yellow coat color
|
J:129904
|
a/a6H
(involves: 101/H * C3H/HeH)
|
abnormal pinna hair pigmentation
|
J:5021
|
darkened coat color
|
J:5021
|
a/a13H
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:90559
|
a/a17H
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:90559
|
a/a19H
(involves: C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:90559
|
a/a20H
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:90559
|
a/atwp
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:16568
|
abnormal ventral coat pigmentation
|
J:16568
|
a/Aw-20J
(involves: C57BL/6J)
|
abnormal coat/hair pigmentation
|
J:79402
|
abnormal ventral coat pigmentation
|
J:79402
|
a/Aw-22J
(involves: C57BL/10GnDgWtRk)
|
abnormal coat/hair pigmentation
|
J:79402
|
abnormal ventral coat pigmentation
|
J:79402
|
a/Ay Bwq2KK/Bwq2KK
(involves: C57BL/6J * KK-Ay)
|
increased body weight
|
J:93199,
J:131439
|
increased susceptibility to weight gain
|
J:93199
|
a/Ay Bwq10C57BL/6J/Bwq10C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased body weight
|
J:131439
|
a/Ay Guq1KK/Guq1KK
(involves: C57BL/6J * KK-Ay)
|
increased urine glucose level
|
J:131439
|
a/Ay Guq2C57BL/6J/Guq2C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased urine glucose level
|
J:131439
|
a/Ay Zc3h4C57BL/6J/Zc3h4KK
(involves: C57BL/6J * KK-Ay)
|
increased body weight
|
J:48704
|
a/Ay Zc3h4KK/Zc3h4KK
(involves: C57BL/6J * KK-Ay)
|
increased body weight
|
J:131439,
J:48704
|
A/? DctSlt-lt/Dct+
(involves: C3H/HeJ)
|
diluted coat color
|
J:27515
|
A/? DctSlt-lt/DctSlt-lt
(involves: C3H/HeJ)
|
diluted coat color
|
J:27515
|
A/? Lystbg/Lystbg Tyrp1+/?
(Not Specified)
|
abnormal eye pigmentation
|
J:29744
|
decreased ear pigmentation
|
J:29744
|
decreased tail pigmentation
|
J:29744
|
diluted coat color
|
J:29744
|
irregular coat pigmentation
|
J:29744
|
A/? Lystbg/Lystbg Tyrp1b/Tyrp1b
(Not Specified)
|
decreased eye pigmentation
|
J:29744
|
diluted coat color
|
J:29744
|
A/? Tyrc/Tyrem1Ove
(involves: C57BL/6 * FVB)
|
decreased eye pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
A/? Tyrc/Tyrem6Ove
(involves: C57BL/6 * FVB)
|
diluted coat color
|
J:94077
|
variegated eye pigmentation pattern
|
J:94077
|
A/? Tyrc/Tyrem7Ove
(involves: C57BL/6 * FVB)
|
diluted coat color
|
J:94077
|
A/? Tyrc/Tyrem12Ove
(involves: C57BL/6 * FVB)
|
diluted coat color
|
J:94077
|
A/? Tyrc/Tyrem13Ove
(involves: C57BL/6 * FVB)
|
pigmentation phenotype
|
J:94077
|
A/? Tyrem1Ove/Tyrem1Ove
(involves: C57BL/6 * FVB)
|
diluted coat color
|
J:94077
|
A/? Tyrem7Ove/Tyrem7Ove
(involves: C57BL/6 * FVB)
|
abnormal eye pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
A/? Tyrem8Ove/Tyrem8Ove
(involves: C57BL/6 * FVB)
|
decreased ear pigmentation
|
J:94077
|
decreased tail pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
variegated eye pigmentation pattern
|
J:94077
|
A/? Tyrem9Ove/Tyrem9Ove
(involves: C57BL/6 * FVB)
|
decreased eye pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
A/? Tyrem12Ove/Tyrem12Ove
(involves: C57BL/6 * FVB)
|
decreased eye pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
A/? Tyrem13Ove/Tyrem13Ove
(involves: C57BL/6 * FVB)
|
pigmentation phenotype
|
J:94077
|
A/a In(11Trp53;11Wnt3)8Brd/+
(either: (involves: 129S7/SvEvBrd * C57BL/6Brd) or (involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6Brd) or (involves: 129S5/SvEvBrd * C57BL/6Brd * C57BL/6J))
|
abnormal tail pigmentation
|
J:56548
|
decreased ear pigmentation
|
J:56548
|
A/a Tyrem15Ove/Tyrem15Ove
(involves: C57BL/6 * FVB)
|
decreased tail pigmentation
|
J:94077
|
diluted coat color
|
J:94077
|
A/a Tyrp1B-lt/Tyrp1B-lt
(Not Specified)
|
diluted coat color
|
J:13094
|
A/A
(Not Specified)
|
no abnormal phenotype detected
|
J:36414
|
pigmentation phenotype
|
J:36414
|
A/A Dkd/Dkd
(LPT;C3-Dkd/GrsrJ)
|
abnormal dorsoventral coat patterning
|
J:137334
|
hearing/vestibular/ear phenotype
|
J:137334
|
vision/eye phenotype
|
J:137334
|
A/A Hps6ru/Hps6ru
(Not Specified)
|
diluted coat color
|
J:13122
|
A/A Mc1rE-tob/Mc1r+
(M. m. domesticus poschiavinus)
|
abnormal coat/hair pigmentation
|
J:22593
|
darkened coat color
|
J:22593
|
A/A Mc1rE-tob/Mc1rE-tob
(M. m. domesticus poschiavinus)
|
abnormal coat/hair pigmentation
|
J:22593
|
darkened coat color
|
J:22593
|
A/A Tyrc-ch/Tyrc-ch
(Not Specified)
|
abnormal coat appearance
|
J:36414
|
abnormal coat/hair pigmentation
|
J:36414
|
abnormal hair follicle pheomelanosome pheomelanin content
|
J:36414
|
A/A U/U
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:78801
|
darkened coat color
|
J:280,
J:78801
|
A/atl
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:169366
|
A/atwp
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:16568
|
abnormal ventral coat pigmentation
|
J:16568
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/0 Tg(CAG-cat,-Trim8)4Holi/0
(involves: C57BL/6J * FVB/N)
|
cardiovascular system phenotype
|
J:303651
|
growth/size/body region phenotype
|
J:303651
|
increased sensitivity to induced morbidity/mortality
|
J:303651
|
mortality/aging
|
J:303651
|
reproductive system phenotype
|
J:303651
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
abnormal myocardium layer morphology
|
J:164749
|
decreased cardiac muscle contractility
|
J:164749
|
dilated cardiomyopathy
|
J:164749
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Ak2em1.1Dze/Ak2em1.1Dze
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal heart echocardiography feature
|
J:305579
|
abnormal metabolism
|
J:305579
|
decreased ventricle muscle contractility
|
J:305579
|
dilated heart ventricle
|
J:305579
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(CAG-cat,-Dusp14)4Lyg/0
(involves: C57BL/6J * FVB/N)
|
cardiac fibrosis
|
J:263251
|
decreased cardiac muscle contractility
|
J:263251
|
decreased response of heart to induced stress
|
J:263251
|
enlarged heart
|
J:263251
|
enlarged myocardial fiber
|
J:263251
|
increased heart weight
|
J:263251
|
increased lung weight
|
J:263251
|
myocardium hypertrophy
|
J:263251
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(CAG-DMPK*)1323Coop/0
(involves: FVB)
|
abnormal cardiac muscle relaxation
|
J:127391
|
abnormal cardiovascular system physiology
|
J:127391
|
abnormal myocardial fiber morphology
|
J:127391
|
atrioventricular block
|
J:127391
|
cardiac interstitial fibrosis
|
J:127391
|
decreased cardiac muscle contractility
|
J:127391
|
decreased diastolic filling velocity
|
J:127391
|
dilated cardiomyopathy
|
J:127391
|
dilated heart left ventricle
|
J:127391
|
enlarged myocardial fiber
|
J:127391
|
irregular heartbeat
|
J:127391
|
premature death
|
J:127391
|
prolonged PR interval
|
J:127391
|
prolonged QRS complex duration
|
J:127391
|
thin ventricular wall
|
J:127391
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(Myh6-2A)#Know/0
(involves: BALB/c * C57BL/6 * FVB/N)
|
abnormal heart echocardiography feature
|
J:128060
|
abnormal intercalated disk morphology
|
J:128060
|
abnormal myocardial fiber morphology
|
J:128060
|
abnormal sarcolemma morphology
|
J:128060
|
abnormal sarcomere morphology
|
J:128060
|
abnormal Z line morphology
|
J:128060
|
ascites
|
J:128060
|
cardiac interstitial fibrosis
|
J:128060
|
decreased cardiac muscle contractility
|
J:128060
|
dilated cardiomyopathy
|
J:128060
|
enlarged heart atrium
|
J:128060
|
heart inflammation
|
J:128060
|
increased heart ventricle size
|
J:128060
|
pleural effusion
|
J:128060
|
A1cftm1b(EUCOMM)Hmgu/A1cftm1b(EUCOMM)Hmgu
(B6N(Cg)-A1cftm1b(EUCOMM)Hmgu/J)
|
increased grip strength
|
J:211773
|
increased heart weight
|
J:211773
|
A1cftm1c(EUCOMM)Hmgu/A1cftm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6N * DBA)
|
abnormal blood homeostasis
|
J:281365
|
abnormal hepatobiliary system physiology
|
J:281365
|
abnormal urine homeostasis
|
J:281365
|
decreased circulating glucose level
|
J:281365
|
decreased circulating insulin level
|
J:281365
|
decreased circulating ketone body level
|
J:281365
|
decreased fasting circulating glucose level
|
J:281365
|
decreased liver triglyceride level
|
J:281365
|
decreased liver weight
|
J:281365
|
decreased susceptibility to diet-induced obesity
|
J:281365
|
decreased urine uric acid level
|
J:281365
|
homeostasis/metabolism phenotype
|
J:281365
|
impaired gluconeogenesis
|
J:281365
|
improved glucose tolerance
|
J:281365
|
increased circulating cholesterol level
|
J:281365
|
increased circulating triglyceride level
|
J:281365
|
increased insulin sensitivity
|
J:281365
|
increased liver glycogen level
|
J:281365
|
A1cftm1Ddsn/A1cftm1Ddsn
(involves: 129X1/SvJ)
|
decreased cell proliferation
|
J:114732
|
embryonic lethality before implantation, complete penetrance
|
J:114732
|
A2ml1em1(IMPC)Tcp/A2ml1+
(C57BL/6N-A2ml1em1(IMPC)Tcp/Tcp)
|
abnormal spleen morphology
|
J:211773
|
abnormal sternum morphology
|
J:211773
|
A2ml1em1(IMPC)Tcp/A2ml1em1(IMPC)Tcp
(C57BL/6N-A2ml1em1(IMPC)Tcp/Tcp)
|
abnormal spleen morphology
|
J:211773
|
preweaning lethality, incomplete penetrance
|
J:211773
|
A3galt2tm1.1Hjg/A3galt2tm1.1Hjg
(involves: 129P2/OlaHsd * BALB/cJ)
|
immune system phenotype
|
J:120323
|
no abnormal phenotype detected
|
J:120323
|
A4galttm1.1Poru/A4galttm1.1Poru Glatm1Kul/Glatm1Kul
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
immune system phenotype
|
J:189359
|
A4galttm1Kfk/A4galttm1Kfk
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:108352
|
decreased sensitivity to xenobiotic induced morbidity/mortality
|
J:108352
|
impaired behavioral response to xenobiotic
|
J:108352
|
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka)
|
abnormal digestive system physiology
|
J:184485
|
abnormal stomach mucosa morphology
|
J:184485
|
increased angiogenesis
|
J:184485
|
increased cell proliferation
|
J:184485
|
increased gastric adenocarcinoma incidence
|
J:184485
|
increased tumor growth/size
|
J:184485
|
stomach epithelial hyperplasia
|
J:184485
|
stomach inflammation
|
J:184485
|
A430005L14Riktm1a(KOMP)Wtsi/A430005L14Riktm1a(KOMP)Wtsi
(C57BL/6N-A430005L14Riktm1a(KOMP)Wtsi/Wtsi)
|
increased bone mineral content
|
J:211773
|
increased bone mineral density
|
J:211773
|
increased lean body mass
|
J:211773
|
A830005F24Riktm1.1(KOMP)Mbp/A830005F24Rik+
(C57BL/6N-A830005F24Riktm1.1(KOMP)Mbp/Ucd)
|
abnormal heart morphology
|
J:211773
|
abnormal kidney morphology
|
J:211773
|
enlarged heart
|
J:211773
|
enlarged kidney
|
J:211773
|
A830005F24Riktm1.1(KOMP)Mbp/A830005F24Riktm1.1(KOMP)Mbp
(C57BL/6N-A830005F24Riktm1.1(KOMP)Mbp/Ucd)
|
abnormal heart morphology
|
J:211773
|
enlarged heart
|
J:211773
|
A830019P07Riktm1a(KOMP)Wtsi/A830019P07Riktm1a(KOMP)Wtsi
(C57BL/6N-A830019P07Riktm1a(KOMP)Wtsi)
|
homeostasis/metabolism phenotype
|
J:287356
|
A830031A19Riktm1b(KOMP)Wtsi/A830031A19Riktm1b(KOMP)Wtsi
(C57BL/6N-A830031A19Riktm1b(KOMP)Wtsi/Wtsi)
|
absent pinna reflex
|
J:211773
|
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
(involves: 129S6/SvEvTac)
|
abnormal cone electrophysiology
|
J:179784
|
abnormal hippocampus granule cell morphology
|
J:179784
|
abnormal retina apoptosis
|
J:179784
|
abnormal retina cone cell morphology
|
J:179784
|
decreased brain size
|
J:179784
|
decreased brain weight
|
J:179784
|
decreased retina cone cell number
|
J:179784
|
increased neuron apoptosis
|
J:179784
|
limb grasping
|
J:179784
|
nervous system phenotype
|
J:179784
|
postnatal lethality, incomplete penetrance
|
J:179784
|
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur Tg(Crx-DsRed,-Mir124a-2)#Tfur/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
vision/eye phenotype
|
J:179784
|
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur Tg(Syn1-DsRed,-Mir124a-2)#Tfur/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
nervous system phenotype
|
J:179784
|
A930017K11Riktm1b(KOMP)Wtsi/A930017K11Riktm1b(KOMP)Wtsi
(C57BL/6N-A930017K11Riktm1b(KOMP)Wtsi/BayMmucd)
|
abnormal retina inner nuclear layer morphology
|
J:211773
|
decreased total retina thickness
|
J:211773
|
a1R/a1R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a2R/a2R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a3R/a3R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a4R/a4R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a5mnu/a5mnu
(involves: 101/H * C3H/HeH)
|
abnormal coat appearance
|
J:16567
|
darkened coat color
|
J:16567
|
a5R/a5R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a6H/a6H
(involves: 101/H * C3H/HeH)
|
abnormal pinna hair pigmentation
|
J:5021
|
darkened coat color
|
J:5021
|
a6R/a6R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a7R/a7R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a8R/a8R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a9R/a9R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a10R/a10R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a11R/a11R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a12R/a12R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a13H/a13H
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:90559
|
abnormal pinna hair pigmentation
|
J:90559
|
a13R/a13R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a14R/a14R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a15R/a15R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a16H/a16H
(involves: 101/H * C3H/HeH)
|
prenatal lethality
|
J:8093
|
a16H/ae
(involves: 101/H * C3H/HeH * P * S)
|
abnormal coat/hair pigmentation
|
J:8093
|
a16H/al
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:9799
|
a16R/a16R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a17H/a17H
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:90559
|
abnormal pinna hair pigmentation
|
J:90559
|
a17R/a17R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a18R/a18R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a19H/a19H
(involves: C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:90559
|
abnormal pinna hair pigmentation
|
J:90559,
J:181531
|
a19R/a19R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a20H/a20H
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:90559
|
abnormal pinna hair pigmentation
|
J:90559
|
abnormal tail hair pigmentation
|
J:90559
|
a20R/a20R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a21R/a21R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a22R/a22R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a23R/a23R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a24R/a24R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
a25R/a25R
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:100221
|
ada/ada
(involves: 101/H * C3H/HeH)
|
abnormal dorsoventral coat patterning
|
J:13694
|
abnormal pinna hair pigmentation
|
J:163587
|
darkened coat color
|
J:13694
|
ae/ae
((P x S)F1)
|
abnormal coat/hair pigmentation
|
J:13070
|
darkened coat color
|
J:13070
|
ae/ae Tbx15de-H/Tbx15de-H
(involves: BTBR * C3H/HeJ * C57BL/6 * P * S)
|
abnormal skeleton morphology
|
J:87455
|
abnormal skin pigmentation
|
J:87455
|
decreased body size
|
J:87455
|
integument phenotype
|
J:87455
|
short hair
|
J:87455
|
aem1(IMPC)Mbp/aem1(IMPC)Mbp
(C57BL/6N-aem1(IMPC)Mbp/MbpMmucd)
|
abnormal kidney morphology
|
J:211773
|
abnormal skin morphology
|
J:211773
|
small kidney
|
J:211773
|
Ahvy/A
(B6.C3-Bpifa2a Ahvy)
|
abnormal coat/hair pigmentation
|
J:24247
|
darkened coat color
|
J:24247
|
irregular coat pigmentation
|
J:24247
|
yellow coat color
|
J:24247
|
Ahvy/Ahvy
(B6.C3-Bpifa2a Ahvy)
|
abnormal coat/hair pigmentation
|
J:24247
|
Aiapy/?
(involves: C3H/HeJ * C57BL/6J)
|
abnormal coat/hair pigmentation
|
J:18848
|
irregular coat pigmentation
|
J:18848
|
maternal effect
|
J:18848
|
mottled coat
|
J:18848
|
obese
|
J:18848
|
yellow coat color
|
J:18848
|
Aiapy/Aiapy
(involves: C3H/HeJ * C57BL/6J)
|
abnormal coat/hair pigmentation
|
J:18848
|
irregular coat pigmentation
|
J:18848
|
mortality/aging
|
J:18848
|
mottled coat
|
J:18848
|
obese
|
J:18848
|
yellow coat color
|
J:18848
|
Aiy/A
(C3H/HeJ-Aiy)
|
abnormal coat/hair pigmentation
|
J:30922
|
mottled coat
|
J:30922
|
obese
|
J:30922
|
yellow coat color
|
J:30922
|
Aiy/Aiy
(C3H/HeJ-Aiy)
|
abnormal coat/hair pigmentation
|
J:30922
|
mottled coat
|
J:30922
|
obese
|
J:30922
|
yellow coat color
|
J:30922
|
ajIs(17;In2)1Gso/ajIs(17;In2)1Gso Fmn1ld-Is(17;In2)1Gso/Fmn1ld-Is(17;In2)1Gso
(involves: 101/Rl * C3H/Rl * C57BL/E * SEC/Rl)
|
abnormal autopod morphology
|
J:10399
|
abnormal carpal bone morphology
|
J:10399
|
abnormal forelimb morphology
|
J:10399
|
abnormal hindlimb morphology
|
J:10399
|
abnormal patella morphology
|
J:10399
|
abnormal radius morphology
|
J:10399
|
abnormal tarsal bone morphology
|
J:10399
|
abnormal ulna morphology
|
J:10399
|
absent fibula
|
J:10399
|
brachydactyly
|
J:10399
|
darkened coat color
|
J:10399
|
dilated ureter
|
J:10399
|
fused carpal bones
|
J:10399
|
fused tarsal bones
|
J:10399
|
hydronephrosis
|
J:10399
|
hydroureter
|
J:10399
|
oligodactyly
|
J:10399
|
radius hypoplasia
|
J:10399
|
renal hypoplasia
|
J:10399
|
single kidney
|
J:10399
|
syndactyly
|
J:10399
|
synostosis
|
J:10399
|
ajl10/a
(Not Specified)
|
darkened coat color
|
J:16567
|
ajl10/ajl10
(Not Specified)
|
prenatal lethality
|
J:16567
|
ajl41/a
(Not Specified)
|
darkened coat color
|
J:16567
|
ajl41/ajl41
(Not Specified)
|
prenatal lethality
|
J:16567
|
ajl85/a
(Not Specified)
|
darkened coat color
|
J:16567
|
ajl85/ajl85
(Not Specified)
|
prenatal lethality
|
J:16567
|
al/a
(involves: 101/H * C3H/HeH)
|
pigmentation phenotype
|
J:9799
|
al/al
(involves: 101/H * C3H/HeH)
|
prenatal lethality
|
J:9799
|
am-J/a
(involves: C3H/HeJ * C57BL/6J)
|
mottled coat
|
J:16570
|
am-J/am-J
(involves: C3H/HeJ * C57BL/6J)
|
maternal imprinting
|
J:16570
|
mottled coat
|
J:16570
|
am/a
(involves: 101/Rl * C3H/Rl)
|
irregular coat pigmentation
|
J:5964,
J:29504
|
maternal effect
|
J:5964
|
mottled coat
|
J:29504
|
Amhdadcc4/Amhdadcc4
(C3FeJ.Cg-Amhdadcc4/Ieg)
|
darkened coat color
|
J:81301
|
Asy/a
(C57BL/6J-Asy/a/J)
|
yellow coat color
|
J:13497
|
Asy/Asy
(C57BL/6J-Asy/a/J)
|
yellow coat color
|
J:13497
|
at-2Gso/at-2Gso
(involves: C57BL/RlGso * SEC/RlGso)
|
abnormal coat/hair pigmentation
|
J:3523
|
at-33J/at-33J
(C57BL/6J-at-33J/J)
|
abnormal dorsoventral coat patterning
|
J:78801
|
at-41J/at-41J
(involves: AKR/J * C57L/J)
|
abnormal coat appearance
|
J:30778,
J:78801
|
abnormal ventral coat pigmentation
|
J:30778
|
at-42J/?
(C57BL/6J-at-42J)
|
abnormal coat/hair pigmentation
|
J:8876
|
abnormal ventral coat pigmentation
|
J:78379
|
at-43J/at-43J
(involves: C3HeB/FeJLe)
|
abnormal coat appearance
|
J:30778,
J:78801
|
abnormal ventral coat pigmentation
|
J:30778
|
at-44J/?
(B6.C/(HZ18)By)
|
abnormal coat/hair pigmentation
|
J:78379
|
abnormal ventral coat pigmentation
|
J:78379
|
at/A As/As+
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:5027
|
at/at
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:78801
|
abnormal dorsoventral coat patterning
|
J:22600,
J:78801
|
at/at As/As
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:5027
|
darkened coat color
|
J:5027
|
at/at Tbx15de-H/Tbx15de-H
(involves: BTBR * C3H/HeJ * C57BL/6)
|
abnormal dorsoventral coat patterning
|
J:87455
|
abnormal ventral coat pigmentation
|
J:87455
|
broad nasal bridge
|
J:87455
|
decreased body size
|
J:87455
|
irregular coat pigmentation
|
J:87455
|
lowered ear position
|
J:87455
|
narrow eye opening
|
J:87455
|
ocular hypertelorism
|
J:87455
|
shortened head
|
J:87455
|
at/atl
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:169366
|
atd/a
(C57BL/6J-atd/J)
|
abnormal coat/hair pigmentation
|
J:13082
|
abnormal dorsoventral coat patterning
|
J:13082
|
abnormal ventral coat pigmentation
|
J:13082
|
atd/atd
(C57BL/6J-atd/J)
|
abnormal coat/hair pigmentation
|
J:13082
|
abnormal dorsoventral coat patterning
|
J:13082
|
abnormal ventral coat pigmentation
|
J:13082
|
atl/atl
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:169366
|
darkened coat color
|
J:169366
|
Atm1.1Arte/a
(C57BL/6NTac-Atm1.1Arte/a)
|
integument phenotype
|
J:213411
|
phenotypic reversion
|
J:213411
|
pigmentation phenotype
|
J:213411
|
Atm1.1Arte/Atm1.1Arte Tyrtm1Arte/Tyrtm1Arte
(C57BL/6NTac-Atm1.1Arte Tyrtm1Arte)
|
absent coat pigmentation
|
J:213411
|
absent eye pigmentation
|
J:213411
|
Atm1Brd/a
(C57BL/6N-Atm1Brd)
|
integument phenotype
|
J:149352
|
pigmentation phenotype
|
J:149352
|
Atm1Brd/Atm1Brd
(C57BL/6N-Atm1Brd)
|
integument phenotype
|
J:149352
|
pigmentation phenotype
|
J:149352
|
Atm1Brd/Atm1Brd Ypel4tm1a(EUCOMM)Wtsi/Ypel4tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Ypel4tm1a(EUCOMM)Wtsi/WtsiIeg)
|
abnormal red blood cell deformability
|
J:313842
|
anisocytosis
|
J:313842
|
elliptocytosis
|
J:313842
|
embryo phenotype
|
J:313842
|
hematopoietic system phenotype
|
J:313842
|
immune system phenotype
|
J:313842
|
increased circulating erythropoietin level
|
J:313842
|
increased hematocrit
|
J:313842
|
increased mean corpuscular volume
|
J:313842
|
macrocytosis
|
J:313842
|
mortality/aging
|
J:313842
|
polycythemia
|
J:313842
|
reticulocytosis
|
J:313842
|
atwp/atwp
(involves: AB/Hum-1)
|
abnormal coat/hair pigmentation
|
J:16568
|
abnormal ventral coat pigmentation
|
J:16568
|
au/a
((C3H/HeH x 101/H)F1)
|
abnormal coat/hair pigmentation
|
J:13694
|
au/au
((C3H/HeH x 101/H)F1)
|
abnormal coat/hair pigmentation
|
J:13694
|
Avy/?
(129S1.C3-Avy)
|
neoplasm
|
J:146879
|
Avy/a
(involves: C3H/HeJ * C57BL/6)
|
abnormal coat/hair pigmentation
|
J:117156
|
abnormal epigenetic regulation of gene expression
|
J:117156
|
increased tumor incidence
|
J:117156
|
obese
|
J:117156
|
variegated coat color
|
J:117156
|
Avy/a
(involves: C57BL/6J)
|
abnormal epigenetic regulation of gene expression
|
J:82396
|
variegated coat color
|
J:82396
|
Avy/a Axin1Fu/Axin1+
(involves: 129P4/RrRk * C67BL/6J)
|
genetic imprinting
|
J:82396
|
Avy/A Dnmt1MommeD2/Dnmt1+
(involves: C57BL/6J * FVB/NJ)
|
yellow coat color
|
J:99816
|
Avy/A Smarca5MommeD4/Smarca5+
(involves: C57BL/6J * FVB/NJ)
|
mottled coat
|
J:99816
|
Avy/A Smchd1MommeD1/Smchd1+
(involves: C57BL/6J * FVB/NJ)
|
yellow coat color
|
J:99816
|
Avy/Avy
(involves: C3H/HeJ)
|
abnormal coat/hair pigmentation
|
J:13080
|
Avy/Aw
(129S1.C3-Avy/Aw Chr 19MOLF/Ei)
|
neoplasm
|
J:146879
|
Aw-15J/a
(involves: C57BL/6J * DBA/2J)
|
abnormal coat/hair pigmentation
|
J:78474
|
abnormal ventral coat pigmentation
|
J:78474
|
Aw-26J/a
(C57BL/6J-Aw-26J/a)
|
abnormal coat/hair pigmentation
|
J:78801
|
abnormal ventral coat pigmentation
|
J:78801
|
Aw-27J/a
(C57BL/6J-Aw-27J)
|
abnormal coat/hair pigmentation
|
J:78801
|
abnormal ventral coat pigmentation
|
J:78801
|
Aw-34J/?
(involves: C57BL/6J)
|
absent coat pigmentation
|
J:16984
|
Aw-35J/?
(involves: C57BL)
|
absent coat pigmentation
|
J:16984
|
Aw-36J/?
(involves: C57BL/6J)
|
absent coat pigmentation
|
J:16984
|
Aw-37J/?
(involves: C57BL/6J)
|
absent coat pigmentation
|
J:16984
|
Aw-38J/?
(involves: C57BL/6J)
|
absent coat pigmentation
|
J:16984
|
Aw-39J/?
(involves: C57BL/6J)
|
absent coat pigmentation
|
J:16984
|
Aw-40J/?
(involves: C57BL/6J)
|
absent coat pigmentation
|
J:16984
|
Aw-41J/?
(involves: C57BL)
|
absent coat pigmentation
|
J:16984
|
Aw-42J/?
(involves: C57BL/6J)
|
absent coat pigmentation
|
J:16984
|
Aw-43J/?
(involves: C57BL/6J)
|
absent coat pigmentation
|
J:16984
|
Aw-46J/a
(C57BL/6J-Aw-46J)
|
abnormal coat/hair pigmentation
|
J:77218
|
abnormal skin pigmentation
|
J:77218
|
Aw-46J/Aw-46J
(C57BL/6J-Aw-46J)
|
abnormal coat/hair pigmentation
|
J:77218
|
abnormal skin pigmentation
|
J:77218
|
Aw-47J/A
(C57BL/6J-Aw-47J)
|
abnormal coat/hair pigmentation
|
J:77218
|
abnormal skin pigmentation
|
J:77218
|
Aw-47J/Aw-47J
(C57BL/6J-Aw-47J)
|
abnormal coat/hair pigmentation
|
J:77218
|
abnormal skin pigmentation
|
J:77218
|
Aw-J/Aw-J
(C57BL/6J-Aw-J/J)
|
abnormal hair follicle melanogenesis
|
J:1295
|
abnormal ventral coat pigmentation
|
J:30922
|
decreased circulating pituitary hormone level
|
J:52183
|
Aw/?
(Not Specified)
|
abnormal ventral coat pigmentation
|
J:22600,
J:78801
|
yellow coat color
|
J:22600
|
Aw/a
(involves: SM/J)
|
endocrine/exocrine gland phenotype
|
J:19308
|
Aw/a Corintm1Bamo/Corintm1Bamo
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
diluted coat color
|
J:130426
|
Aw/at As/As+
(Not Specified)
|
abnormal coat/hair pigmentation
|
J:5027
|
Aw/Aw
(involves: SM/J)
|
abnormal adrenal gland x-zone morphology
|
J:19308
|
endocrine/exocrine gland phenotype
|
J:19308
|
Aw/Aw As/As
(involves: 101/H * C3H/HeH)
|
abnormal coat/hair pigmentation
|
J:5027
|
darkened coat color
|
J:5027
|
Aw/Aw Corintm1Bamo/Corintm1Bamo
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
diluted coat color
|
J:130426
|
ax/a
(involves: 101/Rl * C3H/Rl)
|
abnormal coat/hair pigmentation
|
J:174047
|
abnormal ventral coat pigmentation
|
J:174047
|
ax/a
(B6.Cg-ax)
|
abnormal coat/hair pigmentation
|
J:11953
|
abnormal ventral coat pigmentation
|
J:11953
|
ax/ae
(B6.Cg-ax)
|
abnormal coat/hair pigmentation
|
J:11953
|
abnormal ventral coat pigmentation
|
J:11953
|
ax/ax
(B6.Cg-ax)
|
embryonic growth retardation
|
J:11953
|
embryonic lethality between implantation and placentation, complete penetrance
|
J:11953
|
ax/ax
(involves: 101/Rl * C3H/Rl)
|
embryonic lethality
|
J:174047
|
Ay-J/?
(C3HeB/FeJ-Ay-J)
|
yellow coat color
|
J:78380
|
Ay-Jkn/A
(involves: C57BL/6N)
|
yellow coat color
|
J:129904
|
Ay-Jkn/A Mc1re/Mc1re
(involves: C57BL/6Ha * C57BL/6N)
|
yellow coat color
|
J:129904
|
Ay-Jkn/A Mc1re/Mc1re Tg(MC1R)1Jkn/0
(involves: C57BL/6Ha * C57BL/6N)
|
yellow coat color
|
J:129904
|
Ay/a
(involves: KK)
|
abnormal lipid homeostasis
|
J:26460
|
abnormal pancreatic islet morphology
|
J:26460
|
abnormal renal glomerulus morphology
|
J:26460
|
abnormal renal tubule morphology
|
J:26460
|
degranulated pancreatic beta cells
|
J:26460
|
dilated renal tubule
|
J:26460
|
expanded mesangial matrix
|
J:26460
|
hyperglycemia
|
J:26460
|
impaired glucose tolerance
|
J:26460
|
increased circulating insulin level
|
J:26460
|
increased renal glomerulus basement membrane thickness
|
J:26460
|
increased susceptibility to weight gain
|
J:26460
|
increased total body fat amount
|
J:26460
|
increased urine glucose level
|
J:26460
|
insulin resistance
|
J:26460
|
renal cast
|
J:26460
|
Ay/a
(B6.Cg-Ay/J)
|
abnormal food intake
|
J:102986
|
abnormal hair follicle melanogenesis
|
J:1295
|
Ay/a Agrptm2(DTR)Rpa/Agrp+
(involves: 129S4/SvJaeSor * KK/Upj)
|
abnormal eating behavior
|
J:132184
|
decreased body weight
|
J:132184
|
Ay/a Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
|
abnormal glomerular mesangium morphology
|
J:177084
|
abnormal inflammatory response
|
J:177084
|
abnormal kidney morphology
|
J:177084
|
atherosclerotic lesions
|
J:177084
|
decreased circulating adiponectin level
|
J:177084
|
glomerulosclerosis
|
J:177084
|
hyperglycemia
|
J:177084
|
increased circulating cholesterol level
|
J:177084
|
increased circulating insulin level
|
J:177084
|
increased circulating leptin level
|
J:177084
|
increased circulating triglyceride level
|
J:177084
|
increased monocyte cell number
|
J:177084
|
insulin resistance
|
J:177084
|
obese
|
J:177084
|
Ay/a Apoetm1Unc/Apoetm1Unc Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
|
decreased circulating adiponectin level
|
J:177084
|
homeostasis/metabolism phenotype
|
J:177084
|
increased circulating cholesterol level
|
J:177084
|
increased circulating leptin level
|
J:177084
|
Ay/a Dmbx1tm1Sse/Dmbx1tm1Sse
(involves: ICR)
|
decreased body weight
|
J:125193
|
Ay/a Ednrbs/Ednrbs
(Not Specified)
|
variable body spotting
|
J:12954
|
Ay/a Mssq1KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq2C57BL/6JJcl/Mssq2KK/TaJcl
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq3KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq4KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq5C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq6C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq6KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq7KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq9C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq10KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq11KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq12KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq13C57BL/6JJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq13KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq14KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Mssq16KK/TaJcl/?
(involves: C57BL/6JJcl * KK/TaJcl)
|
large mandible
|
J:143893
|
Ay/a Npbwr1tm1Rck/Npbwr1tm1Rck
(involves: 129P/Ola * C57BL/6J)
|
obese
|
J:94820
|
Ay/a Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK)
|
abnormal eating behavior
|
J:168271
|
adipose tissue phenotype
|
J:168271
|
decreased body weight
|
J:168271
|
decreased circulating glucose level
|
J:168271
|
decreased liver weight
|
J:168271
|
improved glucose tolerance
|
J:168271
|
Ay/a Sik2tm1Htake/Sik2+
(C57BL/6-Sik2tm1Htake)
|
darkened coat color
|
J:215877
|
Ay/a Tg(tetO-Ppargc1a)1Dpk/0 Tg(Tyr-rtTA)37Lc/0
(involves: FVB)
|
abnormal hair follicle melanogenesis
|
J:194191
|
darkened coat color
|
J:194191
|
Ay/a Tyrp1B-lt/?
(Not Specified)
|
yellow coat color
|
J:13094
|
Ay/A
(involves: C57BL/6)
|
decreased locomotor activity
|
J:131039
|
increased body length
|
J:131039
|
increased brown adipose tissue amount
|
J:131039
|
increased circulating leptin level
|
J:131039
|
increased food intake
|
J:131039
|
increased gonadal fat pad weight
|
J:131039
|
increased inguinal fat pad weight
|
J:131039
|
increased liver weight
|
J:131039
|
increased percent body fat/body weight
|
J:131039
|
increased retroperitoneal fat pad weight
|
J:131039
|
increased susceptibility to weight gain
|
J:131039
|
obese
|
J:131039
|
yellow coat color
|
J:131039
|
Ay/A
(involves: C3H/HeJ * C57BL/6J-Ay/a)
|
yellow coat color
|
J:30778
|
Ay/A Pepddal/Pepddal
(involves: C3H/HeJ * CBA/J)
|
darkened coat color
|
J:143333
|
obese
|
J:143333
|
Ay/A Prkar2btm2Gsm/Prkar2b+
(involves: C57BL/6)
|
increased percent body fat/body weight
|
J:131039
|
increased susceptibility to weight gain
|
J:131039
|
polyphagia
|
J:131039
|
Ay/A Prkar2btm2Gsm/Prkar2btm2Gsm
(involves: C57BL/6)
|
behavior/neurological phenotype
|
J:131039
|
growth/size/body region phenotype
|
J:131039
|
increased brown adipose tissue amount
|
J:131039
|
increased gonadal fat pad weight
|
J:131039
|
increased inguinal fat pad weight
|
J:131039
|
increased locomotor activity
|
J:131039
|
increased percent body fat/body weight
|
J:131039
|
increased retroperitoneal fat pad weight
|
J:131039
|
increased susceptibility to weight gain
|
J:131039
|
yellow coat color
|
J:131039
|
Ay/Aw
(129S1.C3-Ay/Aw Chr 19MOLF/Ei)
|
decreased incidence of induced tumors
|
J:146879
|
increased body weight
|
J:146879
|
Ay/Ay
(101-Ay)
|
embryonic lethality
|
J:174504
|
embryonic lethality at implantation, complete penetrance
|
J:174504
|
maternal effect
|
J:174504
|
AA986860em1(IMPC)Mbp/AA986860em1(IMPC)Mbp
(C57BL/6N-AA986860em1(IMPC)Mbp/MbpMmucd)
|
abnormal auditory brainstem response
|
J:211773
|
abnormal kidney morphology
|
J:211773
|
small kidney
|
J:211773
|
Aaastm1Ahue/Aaastm1Ahue
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal motor coordination/balance
|
J:106908
|
cellular phenotype
|
J:106908
|
decreased body weight
|
J:106908
|
decreased exploration in new environment
|
J:106908
|
decreased locomotor activity
|
J:106908
|
digestive/alimentary phenotype
|
J:106908
|
endocrine/exocrine gland phenotype
|
J:106908
|
female infertility
|
J:106908
|
homeostasis/metabolism phenotype
|
J:106908
|
nervous system phenotype
|
J:106908
|
AabprNZB/Slc/?
(involves: NZB/Slc * NZW/Slc)
|
increased B cell proliferation
|
J:87690
|
Aacsem1(IMPC)J/Aacsem1(IMPC)J
(C57BL/6NJ-Aacsem1(IMPC)J/Mmjax)
|
hyperactivity
|
J:211773
|
Aadacem1(IMPC)Mbp/Aadacem1(IMPC)Mbp
(C57BL/6NCrl-Aadacem1(IMPC)Mbp/Mmucd)
|
abnormal eye morphology
|
J:211773
|
abnormal kidney morphology
|
J:211773
|
abnormal spleen morphology
|
J:211773
|
abnormal thymus morphology
|
J:211773
|
abnormal urinary bladder morphology
|
J:211773
|
abnormal uterus morphology
|
J:211773
|
enlarged kidney
|
J:211773
|
hydrometra
|
J:211773
|
small thymus
|
J:211773
|
Aadattm1Tag/Aadattm1Tag
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * Black Swiss))
|
abnormal neuron morphology
|
J:92240
|
abnormal righting response
|
J:92240
|
early eyelid opening
|
J:92240
|
hyperactivity
|
J:92240
|
impaired balance
|
J:92240
|
Aaj1A/J/?
(involves: C57BL/6J * C57BL/6J-Chr1A/J)
|
increased anxiety-related response
|
J:96389
|
Aaj2A/J/Aaj2A/J
(involves: C57BL/6J * C57BL/6J-Chr6A/J)
|
increased anxiety-related response
|
J:96389
|
Aaj3A/J/Aaj3A/J
(involves: C57BL/6J * C57BL/6J-Chr6A/J)
|
increased anxiety-related response
|
J:96389
|
Aaj4A/J/?
(involves: C57BL/6J * C57BL/6J-Chr17A/J)
|
increased anxiety-related response
|
J:96389
|
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl)
|
abnormal auditory brainstem response
|
J:211773
|
abnormal bone structure
|
J:211773
|
abnormal contextual conditioning behavior
|
J:211773
|
abnormal heart left ventricle morphology
|
J:211773
|
abnormal retina outer nuclear layer morphology
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased grip strength
|
J:211773
|
decreased startle reflex
|
J:211773
|
hyperactivity
|
J:211773
|
impaired glucose tolerance
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased prepulse inhibition
|
J:211773
|
increased vertical activity
|
J:211773
|
preweaning lethality, incomplete penetrance
|
J:211773
|
short tibia
|
J:211773
|
Aal/?
(multiple strains)
|
abnormal active avoidance behavior
|
J:5380,
J:8831
|
Aampem1(IMPC)J/Aampem1(IMPC)J
(C57BL/6NJ-Aampem1(IMPC)J/Mmjax)
|
embryonic lethality prior to organogenesis
|
J:211773
|
preweaning lethality, complete penetrance
|
J:211773
|
Aanatrs216509331-A/Aanatrs216509331-A
(C57BL/6J)
|
abnormal pineal gland melatonin secretion
|
J:27126
|
abnormal pineal gland physiology
|
J:27126
|
Aaom1MRL/MpJ/Aaom1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
vascular inflammation
|
J:83832
|
Aapb/?
(involves: C57BL/6J)
|
abnormal active avoidance behavior
|
J:5554
|
Aapd/?
(involves: DBA/2J)
|
abnormal active avoidance behavior
|
J:5554
|
Aaq1C57BL/6J/Aaq1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:43654
|
Aaq1C57BL/6J/Aaq1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:43654
|
Aars2tm1(KOMP)Wtsi/Aars2+
(C57BL/6N-Aars2tm1(KOMP)Wtsi/Nju)
|
abnormal heart left ventricle morphology
|
J:211773
|
abnormal vocalization
|
J:211773
|
decreased red blood cell distribution width
|
J:211773
|
increased basophil cell number
|
J:211773
|
increased eosinophil cell number
|
J:211773
|
increased neutrophil cell number
|
J:211773
|
Aars2tm1(KOMP)Wtsi/Aars2tm1(KOMP)Wtsi
(C57BL/6N-Aars2tm1(KOMP)Wtsi/Nju)
|
preweaning lethality, complete penetrance
|
J:211773
|
Aars2tm1.1Htyy/Aars2+
(involves: 129S6/SvEvTac * C57BL/6JOlaHsd * C57BL/6NCrl)
|
no abnormal phenotype detected
|
J:257856
|
Aars2tm1.1Htyy/Aars2tm1.1Htyy
(involves: 129S6/SvEvTac * C57BL/6JOlaHsd * C57BL/6NCrl)
|
decreased embryo size
|
J:257856
|
embryonic lethality, complete penetrance
|
J:257856
|
Aars2tm2.1Htyy/Aars2+
(involves: 129S6/SvEvTac * C57BL/6JOlaHsd * C57BL/6NCrl)
|
no abnormal phenotype detected
|
J:257856
|
Aars2tm2.1Htyy/Aars2tm2.1Htyy
(involves: 129S6/SvEvTac * C57BL/6JOlaHsd * C57BL/6NCrl)
|
decreased embryo size
|
J:257856
|
embryonic lethality, complete penetrance
|
J:257856
|
Aarssti/Aarssti
(B6.Cg-Aarssti/J)
|
abnormal hair shaft morphology
|
J:110647
|
ataxia
|
J:110647
|
disheveled coat
|
J:110647
|
focal hair loss
|
J:110647
|
hair follicle degeneration
|
J:110647
|
hair follicle outer root sheath hyperplasia
|
J:110647
|
impaired balance
|
J:110647
|
nervous system phenotype
|
J:220153
|
Purkinje cell degeneration
|
J:110647
|
tremors
|
J:110647
|
Aarssti/Aarssti Ankrd16rs251476964-A/Ankrd16rs251476964-A
(involves: C57BL/6J * CAST/Ei)
|
ataxia
|
J:262421
|
Purkinje cell degeneration
|
J:262421
|
Aarssti/Aarssti Ankrd16rs251476964-A/Ankrd16rs251476964-G
(involves: C57BL/6J * CASA/RkJ)
|
behavior/neurological phenotype
|
J:262421
|
nervous system phenotype
|
J:262421
|
neuron degeneration
|
J:262421
|
Aarssti/Aarssti Ankrd16rs251476964-G/Ankrd16rs251476964-G
(involves: C57BL/6J * CAST/Ei)
|
behavior/neurological phenotype
|
J:262421
|
nervous system phenotype
|
J:262421
|
Aarssti/Aarssti Ankrd16tm1.1Slac/Ankrd16tm1.1Slac
(B6.Cg-Ankrd16tm1.1Slac Aarssti)
|
embryonic lethality during organogenesis, complete penetrance
|
J:262421
|
Aarssti/Aarstm1.1Slac
(involves: C57BL/6J * FVB/N)
|
abnormal myocardial fiber morphology
|
J:216802
|
alopecia
|
J:216802
|
cardiac fibrosis
|
J:216802
|
decreased body size
|
J:216802
|
Aarssti/Aarstm1Slac
(involves: C57BL/6J)
|
abnormal autophagy
|
J:216802
|
abnormal cardiovascular system physiology
|
J:216802
|
abnormal mitochondrial morphology
|
J:216802
|
abnormal myocardial fiber morphology
|
J:216802
|
abnormal myocardial fiber physiology
|
J:216802
|
abnormal sarcoplasmic reticulum morphology
|
J:216802
|
alopecia
|
J:216802
|
cardiac fibrosis
|
J:216802
|
cardiac interstitial fibrosis
|
J:216802
|
decreased body size
|
J:216802
|
decreased body weight
|
J:216802
|
decreased cardiac output
|
J:216802
|
decreased ventricle muscle contractility
|
J:216802
|
myocardial fiber disarray
|
J:216802
|
Purkinje cell degeneration
|
J:216802
|
small heart
|
J:216802
|
thin ventricular wall
|
J:216802
|
Aarstm1.1Slac/Aars+
(involves: C57BL/6J * FVB/N)
|
Purkinje cell degeneration
|
J:216802
|
Aarstm1.1Slac/Aarstm1.1Slac
(involves: C57BL/6J * FVB/N)
|
embryonic lethality prior to organogenesis
|
J:216802
|
Aasdhem1(IMPC)Tcp/Aasdhem1(IMPC)Tcp
(C57BL/6N-Aasdhem1(IMPC)Tcp/Tcp)
|
abnormal eye morphology
|
J:211773
|
abnormal sternum morphology
|
J:211773
|
cataract
|
J:211773
|
Aasdhppttm1.1(KOMP)Vlcg/Aasdhppt+
(B6N(Cg)-Aasdhppttm1.1(KOMP)Vlcg/J)
|
abnormal iris pigmentation
|
J:211773
|
decreased grip strength
|
J:211773
|
improved glucose tolerance
|
J:211773
|
Aasdhppttm1.1(KOMP)Vlcg/Aasdhppttm1.1(KOMP)Vlcg
(B6N(Cg)-Aasdhppttm1.1(KOMP)Vlcg/J)
|
embryonic lethality between implantation and somite formation, complete penetrance
|
J:279207
|
embryonic lethality prior to organogenesis
|
J:211773
|
preweaning lethality, complete penetrance
|
J:211773
|
Aassem1(IMPC)Tcp/Aassem1(IMPC)Tcp
(C57BL/6NCrl-Aassem1(IMPC)Tcp/Tcp)
|
abnormal sternum morphology
|
J:211773
|
enlarged lymph nodes
|
J:211773
|
enlarged urinary bladder
|
J:211773
|
Aatfem1(IMPC)J/Aatf+
(C57BL/6NJ-Aatfem1(IMPC)J/Mmjax)
|
hyperactivity
|
J:211773
|
Aatfem1(IMPC)J/Aatfem1(IMPC)J
(C57BL/6NJ-Aatfem1(IMPC)J/Mmjax)
|
embryonic lethality prior to organogenesis
|
J:211773
|
AatfGt(pGT1.8geo)3Pgr/AatfGt(pGT1.8geo)3Pgr
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * NMRI))
|
abnormal cell morphology
|
J:65741
|
abnormal preimplantation embryo development
|
J:65741
|
absent blastocoele
|
J:65741
|
decreased cell proliferation
|
J:65741
|
decreased embryo size
|
J:65741
|
embryonic growth arrest
|
J:65741
|
embryonic lethality before implantation, complete penetrance
|
J:65741
|
failure of blastocyst formation
|
J:65741
|
failure of morula compaction
|
J:65741
|
Aatktm1Shhi/Aatktm1Shhi
(involves: C57BL/6J)
|
abnormal axon morphology
|
J:184851
|
abnormal axonal transport
|
J:184851
|
abnormal neurite morphology
|
J:184851
|
decreased brain size
|
J:184851
|
AB124611tm1.1(KOMP)Vlcg/AB124611tm1.1(KOMP)Vlcg
(C57BL/6N-AB124611tm1.1(KOMP)Vlcg/Ucd)
|
abnormal epididymis morphology
|
J:211773
|
abnormal heart morphology
|
J:211773
|
abnormal kidney morphology
|
J:211773
|
enlarged epididymis
|
J:211773
|
enlarged heart
|
J:211773
|
Abatem2(IMPC)Bay/Abatem2(IMPC)Bay
(C57BL/6N-Abatem2(IMPC)Bay/Bay)
|
preweaning lethality, complete penetrance
|
J:211773
|
Abbp1A/J/Abbp1C57BL/6
(involves: A/J * C57BL/6)
|
increased systemic arterial blood pressure
|
J:86889
|
Abbp1C57BL/6/Abbp1C57BL/6
(involves: A/J * C57BL/6)
|
increased systemic arterial blood pressure
|
J:86889
|
Abbp2C57BL/6/Abbp2C57BL/6
(involves: A/J * C57BL/6)
|
increased systemic arterial blood pressure
|
J:86889
|
Abbp3A/J/Abbp3C57BL/6
(involves: A/J * C57BL/6)
|
increased systemic arterial blood pressure
|
J:86889
|
Abbp3C57BL/6/Abbp3C57BL/6
(involves: A/J * C57BL/6)
|
increased systemic arterial blood pressure
|
J:86889
|
Abbp4C57BL/6/Abbp4C57BL/6
(involves: A/J * C57BL/6)
|
increased systemic arterial blood pressure
|
J:86889
|
Abca1m4620Dajl/Abca1+
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
decreased circulating cholesterol level
|
J:149088
|
decreased circulating HDL cholesterol level
|
J:149088
|
Abca1m4620Dajl/Abca1m4620Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
decreased circulating cholesterol level
|
J:149088
|
decreased circulating HDL cholesterol level
|
J:149088
|
increased circulating triglyceride level
|
J:149088
|
Abca1mpc227H/Abca1mpc227H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
decreased circulating cholesterol level
|
J:234901
|
Abca1tm1.1Jp/Abca1tm1.1Jp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
Abca1tm1b(EUCOMM)Hmgu/Abca1+
(C57BL/6N-Abca1tm1b(EUCOMM)Hmgu/Bay)
|
abnormal locomotor behavior
|
J:211773
|
abnormal retina morphology
|
J:211773
|
unresponsive to tactile stimuli
|
J:211773
|
Abca1tm1b(EUCOMM)Hmgu/Abca1tm1b(EUCOMM)Hmgu
(C57BL/6N-Abca1tm1b(EUCOMM)Hmgu/Bay)
|
abnormal embryo size
|
J:211773
|
preweaning lethality, complete penetrance
|
J:211773
|
unresponsive to tactile stimuli
|
J:211773
|
Abca1tm1Blt/Abca1tm1Blt
(C57BL/6-Abca1tm1Blt)
|
abnormal platelet physiology
|
J:95088
|
Abca1tm1Jdm/Abca1+
(DBA/1LacJ-Abca1tm1Jdm)
|
abnormal circulating phospholipid level
|
J:61679
|
abnormal lipid homeostasis
|
J:61679
|
abnormal lung morphology
|
J:61679
|
decreased circulating cholesterol level
|
J:61679
|
decreased circulating HDL cholesterol level
|
J:61679
|
decreased circulating LDL cholesterol level
|
J:61679
|
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm)
|
abnormal circulating phospholipid level
|
J:61679
|
abnormal fat-soluble vitamin level
|
J:60210
|
abnormal lipid homeostasis
|
J:61679
|
abnormal lung morphology
|
J:61679
|
abnormal placenta development
|
J:63265
|
abnormal pulmonary alveolus morphology
|
J:61679
|
decreased body weight
|
J:60210
|
decreased circulating cholesterol level
|
J:60210,
J:61679
|
decreased circulating HDL cholesterol level
|
J:60210,
J:61679
|
decreased circulating LDL cholesterol level
|
J:61679
|
enlarged adrenal glands
|
J:60210
|
enlarged spleen
|
J:60210
|
female infertility
|
J:63265
|
hemorrhage
|
J:63265
|
impaired macrophage phagocytosis
|
J:63265
|
increased intestinal cholesterol absorption
|
J:61679
|
perinatal lethality, incomplete penetrance
|
J:61679
|
postnatal lethality, incomplete penetrance
|
J:63265
|
thrombocytopenia
|
J:60210
|
Abca1tm1Jdm/Abca1tm1Jdm
(involves: DBA/1LacJ)
|
abnormal cholesterol homeostasis
|
J:89906
|
abnormal Leydig cell morphology
|
J:89906
|
abnormal seminiferous tubule epithelium morphology
|
J:89906
|
abnormal seminiferous tubule morphology
|
J:89906
|
abnormal Sertoli cell morphology
|
J:89906
|
abnormal testosterone level
|
J:89906
|
decreased cholesterol efflux
|
J:89906
|
decreased circulating HDL cholesterol level
|
J:89906
|
decreased circulating phytosterol level
|
J:87209
|
oligozoospermia
|
J:89906
|
reduced male fertility
|
J:89906
|
seminiferous tubule degeneration
|
J:89906
|
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1-Abca1tm1Jdm/J)
|
increased cholesterol efflux
|
J:130777
|
Abca1tm1Jdm/Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ)
|
abnormal thymus morphology
|
J:132254
|
decreased circulating cholesterol level
|
J:132254
|
decreased circulating HDL cholesterol level
|
J:132254
|
homeostasis/metabolism phenotype
|
J:132254
|
impaired macrophage phagocytosis
|
J:132254
|
perinatal lethality, incomplete penetrance
|
J:132254
|
Abca1tm1Jdm/Abca1tm1Jdm Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6 * DBA/1LacJ)
|
abnormal chemokine secretion
|
J:130777
|
abnormal cytokine secretion
|
J:130777
|
decreased cholesterol efflux
|
J:130777
|
Abca1tm1Jdm/Abca1tm1Jdm Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
|
abnormal bone marrow cell morphology/development
|
J:190966
|
abnormal bone structure
|
J:190966
|
abnormal common myeloid progenitor cell morphology
|
J:190966
|
abnormal hematopoietic system physiology
|
J:190966
|
decreased monocyte cell number
|
J:190966
|
extramedullary hematopoiesis
|
J:190966
|
increased hematopoietic stem cell number
|
J:190966
|
increased monocyte cell number
|
J:190966
|
increased neutrophil cell number
|
J:190966
|
Abca1tm1Jdm/Abca1tm1Jdm Abcg1tm1Dgen/Abcg1tm1Dgen Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
|
abnormal hematopoietic system physiology
|
J:190966
|
Abca1tm1Jdm/Abca1tm1Jdm Abcg1tm1Dgen/Abcg1tm1Dgen Tg(APOA1)1Rub/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
|
abnormal hematopoietic system physiology
|
J:190966
|
Abca1tm1Jdm/Abca1tm1Jdm Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/1LacJ * DBA/2)
|
amyloidosis
|
J:105902
|
cerebral amyloid angiopathy
|
J:105902
|
intracerebral hemorrhage
|
J:105902
|
preweaning lethality, incomplete penetrance
|
J:105902
|
Abca1tm1Jdm/Abca1tm1Jdm Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ)
|
abnormal thymus morphology
|
J:132254
|
decreased circulating cholesterol level
|
J:132254
|
decreased circulating HDL cholesterol level
|
J:132254
|
homeostasis/metabolism phenotype
|
J:132254
|
impaired macrophage phagocytosis
|
J:132254
|
perinatal lethality
|
J:132254
|
Abca1tm1Jp/Abca1+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
|
abnormal cholesterol homeostasis
|
J:98093
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
Abca1tm1Jp/Abca1+ Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:107802
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Abcg1tm1Tall/Abcg1tm1Tall Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal bone marrow cell morphology/development
|
J:190966
|
increased interleukin-17 secretion
|
J:190966
|
increased interleukin-23 secretion
|
J:190966
|
Abca1tm1Jp/Abca1tm1Jp Abcg1tm1Tall/Abcg1tm1Tall Tg(Itgax-cre,-EGFP)4097Ach/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
abnormal bone marrow cell morphology/development
|
J:190966
|
increased interleukin-17 secretion
|
J:190966
|
increased interleukin-23 secretion
|
J:190966
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
|
abnormal cholesterol homeostasis
|
J:98093
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
decreased circulating LDL cholesterol level
|
J:98093
|
increased circulating triglyceride level
|
J:98093
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA * SJL)
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal enterocyte physiology
|
J:107802
|
decreased cholesterol efflux
|
J:107802
|
decreased circulating cholesterol level
|
J:107802
|
decreased circulating HDL cholesterol level
|
J:107802
|
decreased circulating LDL cholesterol level
|
J:107802
|
Abca1tm1Wpfl/Abca1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal placenta labyrinth morphology
|
J:64390
|
cardiomyopathy
|
J:64390
|
decreased circulating cholesterol level
|
J:64390
|
decreased circulating HDL cholesterol level
|
J:64390
|
heart left ventricle hypertrophy
|
J:64390
|
heart right ventricle hypertrophy
|
J:64390
|
lung hemorrhage
|
J:64390
|
reduced female fertility
|
J:64390
|
respiratory distress
|
J:64390
|
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal adrenal gland morphology
|
J:64390
|
abnormal kidney cortex morphology
|
J:64390
|
abnormal ovary morphology
|
J:64390
|
abnormal placenta labyrinth morphology
|
J:64390
|
abnormal Sertoli cell morphology
|
J:64390
|
abnormal thymus morphology
|
J:64390
|
abnormal uterus morphology
|
J:64390
|
cardiomyopathy
|
J:64390
|
decreased body size
|
J:64390
|
decreased circulating cholesterol level
|
J:68431,
J:64390
|
decreased circulating estradiol level
|
J:64390
|
decreased circulating HDL cholesterol level
|
J:68431,
J:64390
|
decreased circulating progesterone level
|
J:64390
|
decreased intestinal cholesterol absorption
|
J:68431
|
embryonic growth arrest
|
J:64390
|
embryonic growth retardation
|
J:64390
|
glomerulonephritis
|
J:64390
|
glomerulosclerosis
|
J:64390
|
heart left ventricle hypertrophy
|
J:64390
|
heart right ventricle hypertrophy
|
J:64390
|
lethality throughout fetal growth and development, incomplete penetrance
|
J:64390
|
lung hemorrhage
|
J:64390
|
macrovesicular hepatic steatosis
|
J:64390
|
placenta hemorrhage
|
J:64390
|
postnatal lethality, incomplete penetrance
|
J:64390
|
reduced female fertility
|
J:64390
|
renal glomerular immunoglobulin deposits
|
J:64390
|
respiratory distress
|
J:64390
|
uterus inflammation
|
J:64390
|
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129 * C57BL/6)
|
abnormal Sertoli cell morphology
|
J:101966
|
Abca1tm1Wpfl/Abca1tm1Wpfl Npc1m1N/Npc1m1N
(involves: 129P2/OlaHsd * BALB/c)
|
decreased brain cholesterol level
|
J:130969
|
increased cholesterol level
|
J:130969
|
premature death
|
J:130969
|
Abca1tm2Jp/Abca1+ Tg(APOA1)427Bres/?
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal circulating cholesterol level
|
J:104719
|
abnormal circulating protein level
|
J:104719
|
decreased circulating HDL cholesterol level
|
J:104719
|
decreased circulating phospholipid level
|
J:104719
|
Abca1tm2Jp/Abca1tm2Jp Tg(APOA1)427Bres/?
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal circulating cholesterol level
|
J:104719
|
abnormal circulating protein level
|
J:104719
|
abnormal kidney physiology
|
J:104719
|
decreased circulating HDL cholesterol level
|
J:104719
|
decreased circulating phospholipid level
|
J:104719
|
Abca2em1(IMPC)J/Abca2em1(IMPC)J
(C57BL/6NJ-Abca2em1(IMPC)J/Mmjax)
|
hyperactivity
|
J:211773
|
increased exploration in new environment
|
J:211773
|
Abca2tm1Kdt/Abca2tm1Kdt
(involves: 129)
|
abnormal motor coordination/balance
|
J:117673
|
abnormal myelin sheath morphology
|
J:117673
|
decreased body weight
|
J:117673
|
enhanced coordination
|
J:117673
|
increased fear-related response
|
J:117673
|
increased locomotor activity
|
J:117673
|
increased startle reflex
|
J:117673
|
increased vertical activity
|
J:117673
|
tremors
|
J:117673
|
Abca2tm1Nina/Abca2tm1Nina
(involves: 129X1/SvJ * C57BL/6)
|
abnormal emotion/affect behavior
|
J:123521
|
abnormal lipid level
|
J:123521
|
decreased body weight
|
J:123521
|
impaired balance
|
J:123521
|
increased sensitivity to induced morbidity/mortality
|
J:123521
|
reduced female fertility
|
J:123521
|
tremors
|
J:123521
|
Abca3tm1b(EUCOMM)Hmgu/Abca3tm1b(EUCOMM)Hmgu
(C57BL/6N-Abca3tm1b(EUCOMM)Hmgu/Bay)
|
preweaning lethality, complete penetrance
|
J:211773
|
Abca3tm1Dgen/Abca3+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal lung development
|
J:124809
|
abnormal surfactant physiology
|
J:124809
|
decreased alveolar lamellar body number
|
J:124809
|
Abca3tm1Dgen/Abca3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal pulmonary alveolus morphology
|
J:124809
|
abnormal surfactant secretion
|
J:124809
|
absent alveolar lamellar bodies
|
J:124809
|
neonatal lethality, complete penetrance
|
J:124809
|
prenatal lethality, incomplete penetrance
|
J:124809
|
thick pulmonary interalveolar septum
|
J:124809
|
Abca3tm1Frm/Abca3tm1Frm
(involves: 129S/SvEv)
|
abnormal lipid homeostasis
|
J:120296
|
abnormal surfactant secretion
|
J:120296
|
absent alveolar lamellar bodies
|
J:120296
|
cyanosis
|
J:120296
|
lethargy
|
J:120296
|
neonatal lethality, complete penetrance
|
J:120296
|
primary atelectasis
|
J:120296
|
pulmonary alveolar hemorrhage
|
J:120296
|
renal/urinary system phenotype
|
J:120296
|
respiratory failure
|
J:120296
|
Abca3tm1Holz/Abca3tm1Holz
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal alveolar lamellar body morphology
|
J:122736
|
abnormal surfactant physiology
|
J:122736
|
abnormal type II pneumocyte morphology
|
J:122736
|
atelectasis
|
J:122736
|
cyanosis
|
J:122736
|
lethargy
|
J:122736
|
neonatal lethality, complete penetrance
|
J:122736
|
respiratory distress
|
J:122736
|
respiratory failure
|
J:122736
|
Abca3tm1Nina/Abca3tm1Nina
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal alveolar lamellar body morphology
|
J:121155
|
abnormal bronchiole epithelium morphology
|
J:121155
|
abnormal lung development
|
J:121155
|
abnormal lung saccule morphology
|
J:121155
|
abnormal surfactant composition
|
J:121155
|
abnormal type II pneumocyte morphology
|
J:121155
|
absent alveolar lamellar bodies
|
J:121155
|
absent type I pneumocytes
|
J:121155
|
atelectasis
|
J:121155
|
cyanosis
|
J:121155
|
increased wet-to-dry lung weight ratio
|
J:121155
|
neonatal lethality, complete penetrance
|
J:121155
|
pulmonary vascular congestion
|
J:121155
|
respiratory failure
|
J:121155
|
thick lung-associated mesenchyme
|
J:121155
|
Abca4tm1.1Rsmy/Abca4tm1.1Rsmy
(involves: C57BL/6)
|
abnormal eye physiology
|
J:255529
|
abnormal retina pigment epithelium morphology
|
J:255529
|
Abca4tm1a(EUCOMM)Wtsi/Abca4+
(C57BL/6N-Abca4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Abca4tm1a(EUCOMM)Wtsi/Abca4tm1a(EUCOMM)Wtsi
(C57BL/6N-Abca4tm1a(EUCOMM)Wtsi/Wtsi)
|
vertebral fusion
|
J:211773
|
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae * C57BL/6)
|
abnormal Bruch membrane morphology
|
J:56317
|
abnormal eye physiology
|
J:56317
|
abnormal photoreceptor outer segment morphology
|
J:56317
|
abnormal retina pigment epithelium morphology
|
J:56317
|
delayed dark adaptation
|
J:56317
|
retina photoreceptor degeneration
|
J:56317
|
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae)
|
abnormal eye physiology
|
J:117483
|
abnormal retina pigment epithelium morphology
|
J:141801
|
abnormal vitamin A level
|
J:141801
|
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae * BALB/c)
|
abnormal retina pigment epithelium morphology
|
J:141801
|
photoreceptor outer segment degeneration
|
J:141801
|
thin retina outer nuclear layer
|
J:141801
|
Abca4tm1Ght/Abca4tm1Ght Rdh8tm1Kpal/Rdh8tm1Kpal
(involves: 129 * 129S4/SvJae)
|
abnormal Bruch membrane morphology
|
J:154536
|
abnormal cone electrophysiology
|
J:154536
|
abnormal eye electrophysiology
|
J:154536
|
abnormal retina photoreceptor morphology
|
J:154536
|
abnormal retina pigment epithelium morphology
|
J:154536
|
abnormal retina pigmentation
|
J:154536
|
abnormal rod electrophysiology
|
J:154536
|
choroidal neovascularization
|
J:154536
|
decreased retina cone cell number
|
J:154536
|
decreased retina photoreceptor cell number
|
J:154536
|
retina degeneration
|
J:154536
|
retina deposits
|
J:154536
|
thin retina outer nuclear layer
|
J:154536
|
Abca4tm1Kpal/Abca4tm1Kpal Rdh8tm1Kpal/Rdh8tm1Kpal
(involves: 129)
|
abnormal eye morphology
|
J:213619
|
Abca4tm2.1Kpal/Abca4tm2.1Kpal
(involves: 129 * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * C57BL/6N)
|
lipofuscinosis
|
J:221141
|
vision/eye phenotype
|
J:221141
|
Abca4tm2.1Kpal/Abca4tm2.1Kpal Gnat1tm1Clma/Gnat1tm1Clma
(involves: 129 * C57BL/6 * C57BL/6N)
|
abnormal cone electrophysiology
|
J:221141
|
lipofuscinosis
|
J:221141
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
|
abnormal cardiac thrombosis
|
J:99152
|
abnormal liver physiology
|
J:99152
|
abnormal thyroid follicle morphology
|
J:99152
|
absent thyroid gland
|
J:99152
|
decreased activity of thyroid gland
|
J:99152
|
dilated cardiomyopathy
|
J:99152
|
exophthalmos
|
J:99152
|
myocardial fiber degeneration
|
J:99152
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
abnormal cardiac thrombosis
|
J:99152
|
abnormal liver morphology
|
J:99152
|
abnormal thyroid follicle morphology
|
J:99152
|
absent thyroid gland
|
J:99152
|
decreased activity of thyroid gland
|
J:99152
|
dilated cardiomyopathy
|
J:99152
|
edema
|
J:99152
|
exophthalmos
|
J:99152
|
myocardial fiber degeneration
|
J:99152
|
premature death
|
J:99152
|
tremors
|
J:99152
|
visceral vascular congestion
|
J:99152
|
Abca6em1Nju/Abca6em1Nju
(C57BL/6J-Abca6em1Nju)
|
growth/size/body region phenotype
|
J:311129
|
homeostasis/metabolism phenotype
|
J:311129
|
Abca6tm2b(KOMP)Wtsi/Abca6tm2b(KOMP)Wtsi
(C57BL/6N-Abca6tm2b(KOMP)Wtsi/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased hematocrit
|
J:211773
|
Abca7tm1Frm/Abca7tm1Frm
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:96865
|
decreased circulating HDL cholesterol level
|
J:96865
|
decreased white adipose tissue amount
|
J:96865
|
small kidney
|
J:96865
|
Abca7tm2b(EUCOMM)Hmgu/Abca7tm2b(EUCOMM)Hmgu
(B6N(Cg)-Abca7tm2b(EUCOMM)Hmgu/J)
|
abnormal sleep behavior
|
J:211773
|
decreased circulating chloride level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Abca8aem1(IMPC)J/Abca8aem1(IMPC)J
(C57BL/6NJ-Abca8aem1(IMPC)J/Mmjax)
|
preweaning lethality, incomplete penetrance
|
J:211773
|
Abca8btm1a(EUCOMM)Wtsi/Abca8btm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating cholesterol level
|
J:269226
|
decreased circulating HDL cholesterol level
|
J:269226
|
decreased circulating LDL cholesterol level
|
J:269226
|
decreased circulating triglyceride level
|
J:269226
|
Abca9em1(IMPC)J/Abca9em1(IMPC)J
(C57BL/6NJ-Abca9em1(IMPC)J/J)
|
decreased thigmotaxis
|
J:211773
|
Abca12el12/Abca12+
(involves: 129/Sv * C57BL/6)
|
abnormal lipid homeostasis
|
J:161652
|
decreased cholesterol efflux
|
J:161652
|
Abca12el12/Abca12el12
(involves: 129/Sv * C57BL/6)
|
abnormal corneocyte envelope morphology
|
J:161652
|
abnormal epidermal lamellar body morphology
|
J:161652
|
abnormal epidermis stratum basale morphology
|
J:161652
|
abnormal lipid homeostasis
|
J:161652
|
abnormal skin development
|
J:161652
|
abnormal skin morphology
|
J:161652
|
absent suckling reflex
|
J:161652
|
decreased cholesterol efflux
|
J:161652
|
decreased fetal size
|
J:161652
|
dehydration
|
J:161652
|
hyperkeratosis
|
J:161652
|
impaired skin barrier function
|
J:161652
|
increased cholesterol level
|
J:161652
|
neonatal lethality, complete penetrance
|
J:161652
|
thick epidermis stratum granulosum
|
J:161652
|
thin epidermis
|
J:161652
|
thin epidermis stratum spinosum
|
J:161652
|
tight skin
|
J:161652
|
Abca12em1(IMPC)J/Abca12+
(C57BL/6NJ-Abca12em1(IMPC)J/Mmjax)
|
decreased grip strength
|
J:211773
|
Abca12em1(IMPC)J/Abca12em1(IMPC)J
(C57BL/6NJ-Abca12em1(IMPC)J/Mmjax)
|
abnormal facial morphology
|
J:211773
|
abnormal outer ear morphology
|
J:211773
|
abnormal skin appearance
|
J:211773
|
edema
|
J:211773
|
preweaning lethality, complete penetrance
|
J:211773
|
Abca12smsk/Abca12smsk
(involves: C57BL/6J)
|
abnormal epidermal lamellar body morphology
|
J:262458
|
abnormal epidermis stratum basale morphology
|
J:262458
|
abnormal epidermis stratum corneum morphology
|
J:262458
|
abnormal keratinocyte physiology
|
J:262458
|
abnormal skin development
|
J:262458
|
dehydration
|
J:262458
|
dry skin
|
J:262458
|
hyperkeratosis
|
J:262458
|
impaired skin barrier function
|
J:262458
|
impaired stratum corneum desquamation
|
J:262458
|
parakeratosis
|
J:262458
|
perinatal lethality, complete penetrance
|
J:262458
|
shiny skin
|
J:262458
|
thick epidermis stratum granulosum
|
J:262458
|
thin epidermis stratum spinosum
|
J:262458
|
tight skin
|
J:262458
|
translucent skin
|
J:262458
|
Abca12tm1Lex/Abca12tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
preweaning lethality, complete penetrance
|
J:103485
|
Abca12tm1Lex/Abca12tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
|
abnormal epidermal lamellar body morphology
|
J:144062
|
abnormal lipid homeostasis
|
J:144062
|
epidermal desquamation
|
J:144062
|
hyperkeratosis
|
J:144062
|
impaired skin barrier function
|
J:144062
|
neonatal lethality, complete penetrance
|
J:144062
|
parakeratosis
|
J:144062
|
Abca12tm1Shzu/Abca12tm1Shzu
(B6.129S-Abca12tm1Shzu)
|
abnormal epidermal lamellar body morphology
|
J:139048
|
abnormal epidermal layer morphology
|
J:139048
|
abnormal pulmonary alveolus morphology
|
J:139048
|
abnormal skin condition
|
J:139048
|
abnormal skin development
|
J:139048
|
abnormal surfactant secretion
|
J:139048
|
abnormal type II pneumocyte morphology
|
J:139048
|
absent alveolar lamellar bodies
|
J:139048
|
atelectasis
|
J:139048
|
decreased birth weight
|
J:139048
|
decreased fetal weight
|
J:139048
|
dehydration
|
J:139048
|
eclabion
|
J:139048
|
hyperkeratosis
|
J:139048
|
impaired skin barrier function
|
J:139048
|
neonatal lethality, complete penetrance
|
J:139048
|
pulmonary vascular congestion
|
J:139048
|
reddish skin
|
J:139048
|
scaly skin
|
J:139048
|
shiny skin
|
J:139048
|
skin lesions
|
J:139048
|
thick pulmonary interalveolar septum
|
J:139048
|
tight skin
|
J:139048
|
Abca13tm1b(EUCOMM)Wtsi/Abca13tm1b(EUCOMM)Wtsi
(C57BL/6N-Abca13tm1b(EUCOMM)Wtsi/Bay)
|
abnormal male genitalia morphology
|
J:211773
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased prepulse inhibition
|
J:211773
|
Abca14tm1.1(NCOM)Mfgc/Abca14tm1.1(NCOM)Mfgc
(C57BL/6N-Abca14tm1.1(NCOM)Mfgc/Tcp)
|
increased eosinophil cell number
|
J:211773
|
Abca16em1(IMPC)J/Abca16em1(IMPC)J
(C57BL/6NJ-Abca16em1(IMPC)J/J)
|
abnormal cornea morphology
|
J:211773
|
abnormal lens morphology
|
J:211773
|
increased grip strength
|
J:211773
|
limb grasping
|
J:211773
|
Abca17tm1b(EUCOMM)Wtsi/Abca17tm1b(EUCOMM)Wtsi
(C57BL/6N-Abca17tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating potassium level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Abcb1amds/Abcb1amds
(involves: CF-1)
|
abnormal hippocampus CA3 region morphology
|
J:64725
|
catalepsy
|
J:64725
|
hippocampal neuron degeneration
|
J:64725
|
increased eosinophil cell number
|
J:64725
|
increased physiological sensitivity to xenobiotic
|
J:40292,
J:64725
|
premature death
|
J:64725
|
tremors
|
J:64725
|
Abcb1atm1Bor/Abcb1atm1Bor
(involves: 129P2/OlaHsd * FVB)
|
abnormal xenobiotic pharmacokinetics
|
J:39804
|
impaired blood-brain barrier function
|
J:18554
|
increased physiological sensitivity to xenobiotic
|
J:18554
|
Abcb1atm1Bor/Abcb1atm1Bor
(FVBTac.129P2-Abcb1atm1Bor)
|
abnormal blood-inner ear barrier function
|
J:59145
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:102640
|
abnormal xenobiotic pharmacokinetics
|
J:59145,
J:102640
|
decreased gamma-delta intraepithelial T cell number
|
J:102640
|
increased physiological sensitivity to xenobiotic
|
J:59145
|
increased susceptibility to ototoxicity-induced hearing loss
|
J:59145
|
Abcb1atm1Bor/Abcb1atm1Bor
(FVB.129P2-Abcb1atm1Bor/TacImx)
|
abnormal intestinal epithelium morphology
|
J:51190
|
abnormal intestinal mucosa morphology
|
J:51190
|
abnormal large intestine crypts of Lieberkuhn morphology
|
J:51190
|
abnormal lymphocyte physiology
|
J:51190
|
cachexia
|
J:51190
|
colitis
|
J:51190
|
crypts of Lieberkuhn abscesses
|
J:51190
|
increased IgA level
|
J:51190
|
increased IgE level
|
J:51190
|
increased IgG1 level
|
J:51190
|
increased IgG2 level
|
J:51190
|
increased IgG2a level
|
J:51190
|
increased IgG2b level
|
J:51190
|
increased IgG3 level
|
J:51190
|
increased IgM level
|
J:51190
|
increased immunoglobulin level
|
J:51190
|
intestinal ulcer
|
J:51190
|
large intestinal inflammation
|
J:51190
|
mucous diarrhea
|
J:51190
|
Abcb1atm1Bor/Abcb1atm1Bor Abcb1btm1Bor/Abcb1btm1Bor
(involves: 129P2/OlaHsd * FVB)
|
abnormal xenobiotic pharmacokinetics
|
J:39804
|
Abcb1atm1Bor/Abcb1atm1Bor Abcb1btm1Bor/Abcb1btm1Bor
(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:102640
|
abnormal T cell physiology
|
J:102640
|
abnormal xenobiotic pharmacokinetics
|
J:102640,
J:107822
|
decreased gamma-delta intraepithelial T cell number
|
J:102640
|
increased double-positive T cell number
|
J:102640
|
increased interferon-gamma secretion
|
J:102640
|
increased interleukin-2 secretion
|
J:102640
|
Abcb1atm1Bor/Abcb1atm1Bor Abcb1btm1Bor/Abcb1btm1Bor Abcc2tm1Ahs/Abcc2tm1Ahs
(FVB.129P2-Abcb1btm1Bor Abcb1atm1Bor Abcc2tm1Ahs)
|
abnormal xenobiotic pharmacokinetics
|
J:107822
|
Abcb1atm1Bor/Abcb1atm1Bor Abcb1btm1Bor/Abcb1btm1Bor Tg(Thy1-AppDutch)#Jckr/0
(FVB.Cg-Abcb1btm1Bor Abcb1atm1Bor Tg(Thy1-AppDutch)#Jckr)
|
amyloid beta deposits
|
J:178230
|
Abcb1atm1Bor/Abcb1atm1Bor Abcb1btm1Bor/Abcb1btm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0
(FVB.Cg-Abcb1btm1Bor Abcb1atm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
|
amyloid beta deposits
|
J:178230
|
Abcb1atm1Bor/Abcb1atm1Bor Npc1m1N/Npc1m1N
(involves: 129/Ola * BALB/c)
|
abnormal maternal nurturing
|
J:76395
|
abnormal motor capabilities/coordination/movement
|
J:76395
|
increased liver cholesterol level
|
J:76395
|
reproductive system phenotype
|
J:76395
|
Abcb1atm1Kane/Abcb1a+
(involves: 129S1/SvImJ)
|
no phenotypic analysis
|
J:147139
|
Abcb1btm2Bor/Abcb1btm2Bor
(involves: 129P2/OlaHsd * FVB)
|
abnormal xenobiotic pharmacokinetics
|
J:39804
|
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased hemoglobin content
|
J:211773
|
decreased mean corpuscular hemoglobin
|
J:211773
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
increased basophil cell number
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased leukocyte cell number
|
J:211773
|
increased lymphocyte cell number
|
J:211773
|
increased monocyte cell number
|
J:211773
|
increased neutrophil cell number
|
J:211773
|
increased red blood cell distribution width
|
J:211773
|
increased spleen weight
|
J:211773
|
thrombocytosis
|
J:211773
|
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal bile canaliculus morphology
|
J:15531,
J:21232
|
abnormal bile composition
|
J:15531
|
abnormal bile duct morphology
|
J:15531
|
abnormal bile secretion
|
J:15531
|
abnormal blood homeostasis
|
J:15531
|
abnormal circulating alanine transaminase level
|
J:15531
|
abnormal circulating alkaline phosphatase level
|
J:15531
|
abnormal circulating aspartate transaminase level
|
J:15531
|
abnormal circulating bilirubin level
|
J:15531
|
abnormal hepatobiliary system morphology
|
J:21232
|
abnormal hepatobiliary system physiology
|
J:21232
|
abnormal hepatocyte morphology
|
J:15531
|
abnormal portal triad morphology
|
J:21232
|
bile duct inflammation
|
J:15531,
J:21232
|
bile duct proliferation
|
J:21232
|
biliary cirrhosis
|
J:21232
|
cholestasis
|
J:21232
|
dilated bile duct
|
J:15531
|
enlarged liver
|
J:21232
|
hepatic necrosis
|
J:21232
|
increased hepatocellular carcinoma incidence
|
J:21232
|
intrahepatic cholestasis
|
J:15531
|
liver hemorrhage
|
J:21232
|
liver inflammation
|
J:15531
|
reduced female fertility
|
J:21232
|
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal circulating enzyme level
|
J:114411
|
abnormal feces composition
|
J:175015
|
abnormal hepatocyte morphology
|
J:175015
|
abnormal intestine physiology
|
J:175015
|
abnormal lipid homeostasis
|
J:114411
|
abnormal sodium ion homeostasis
|
J:175015
|
bile duct inflammation
|
J:175015
|
decreased circulating cholesterol level
|
J:114411
|
decreased intestinal cholesterol absorption
|
J:114411
|
focal hepatic necrosis
|
J:175015
|
increased bile salt level
|
J:175015
|
increased circulating alanine transaminase level
|
J:114411,
J:175015
|
increased circulating aspartate transaminase level
|
J:114411
|
increased circulating bilirubin level
|
J:114411
|
intrahepatic cholestasis
|
J:175015
|
liver inflammation
|
J:175015
|
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
|
abnormal bile composition
|
J:100491,
J:105357
|
abnormal bile duct morphology
|
J:105357
|
abnormal circulating enzyme level
|
J:105357
|
abnormal feces composition
|
J:100491
|
abnormal gallbladder size
|
J:105357
|
abnormal liver morphology
|
J:105357
|
bile duct inflammation
|
J:105357
|
dilated bile duct
|
J:105357
|
enlarged liver
|
J:105357
|
enlarged spleen
|
J:217802
|
gallstones
|
J:105357
|
homeostasis/metabolism phenotype
|
J:100491
|
increased circulating alanine transaminase level
|
J:100491,
J:217802
|
increased circulating alkaline phosphatase level
|
J:105357,
J:217802
|
increased circulating aspartate transaminase level
|
J:100491,
J:217802
|
increased circulating bilirubin level
|
J:105357,
J:217802
|
increased hepatocellular carcinoma incidence
|
J:217802
|
intrahepatic cholestasis
|
J:105357
|
liver cirrhosis
|
J:217802
|
liver fibrosis
|
J:217802
|
portal hypertension
|
J:217802
|
Abcb4tm1Bor/Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor)
|
abnormal bone remodeling
|
J:199949
|
abnormal compact bone morphology
|
J:199949
|
abnormal enzyme/coenzyme activity
|
J:199949
|
abnormal trabecular bone morphology
|
J:199949
|
abnormal trabecular bone volume
|
J:199949
|
decreased bone mineral content
|
J:199949
|
decreased bone mineral density
|
J:199949
|
decreased bone trabecula number
|
J:199949
|
decreased bone volume
|
J:199949
|
decreased circulating calcium level
|
J:199949
|
decreased trabecular bone connectivity density
|
J:199949
|
decreased vitamin D level
|
J:199949
|
increased alkaline phosphatase activity
|
J:199949
|
increased circulating phosphate level
|
J:199949
|
increased transforming growth factor beta level
|
J:199949
|
increased tumor necrosis factor (ligand) superfamily member 11 level
|
J:199949
|
liver fibrosis
|
J:199949
|
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * BALB/c)
|
bile duct inflammation
|
J:168123
|
decreased systemic arterial systolic blood pressure
|
J:168123
|
liver fibrosis
|
J:168123
|
Abcb4tm1Bor/Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor)
|
enlarged spleen
|
J:217802
|
increased circulating alanine transaminase level
|
J:217802
|
increased circulating alkaline phosphatase level
|
J:217802
|
increased circulating aspartate transaminase level
|
J:217802
|
increased circulating bilirubin level
|
J:217802
|
increased hepatocellular carcinoma incidence
|
J:217802
|
liver cirrhosis
|
J:217802
|
liver fibrosis
|
J:217802
|
portal hypertension
|
J:217802
|
weight loss
|
J:217802
|
Abcb4tm1Bor/Abcb4tm1Bor Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal feces composition
|
J:175015
|
abnormal intestine physiology
|
J:175015
|
decreased bile salt level
|
J:175015
|
decreased circulating alanine transaminase level
|
J:175015
|
liver/biliary system phenotype
|
J:175015
|
Abcb4tm1Bor/Abcb4tm1Bor Portm1Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N)
|
abnormal bile salt homeostasis
|
J:215915
|
bile duct proliferation
|
J:215915
|
cholestasis
|
J:215915
|
growth/size/body region phenotype
|
J:215915
|
increased bile salt level
|
J:215915
|
increased circulating alanine transaminase level
|
J:215915
|
increased circulating alkaline phosphatase level
|
J:215915
|
increased circulating bilirubin level
|
J:215915
|
increased hepatocyte proliferation
|
J:215915
|
increased liver weight
|
J:215915
|
liver fibrosis
|
J:215915
|
Abcb4tm1Bor/Abcb4tm1Bor Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
abnormal bile composition
|
J:100491
|
abnormal feces composition
|
J:100491
|
decreased intestinal cholesterol absorption
|
J:100491
|
homeostasis/metabolism phenotype
|
J:100491
|
increased circulating alanine transaminase level
|
J:100491
|
increased circulating aspartate transaminase level
|
J:100491
|
Abcb5tm1.2Nyf/Abcb5tm1.2Nyf
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal cornea morphology
|
J:213708
|
abnormal corneal epithelium morphology
|
J:213708
|
abnormal corneal wound healing
|
J:213708
|
abnormal eye physiology
|
J:213708
|
abnormal photoreceptor inner segment morphology
|
J:213708
|
abnormal photoreceptor outer segment morphology
|
J:213708
|
abnormal retina morphology
|
J:213708
|
abnormal retina outer nuclear layer morphology
|
J:213708
|
abnormal retina pigment epithelium morphology
|
J:213708
|
corneal epithelium hypoplasia
|
J:213708
|
increased cell proliferation
|
J:213708
|
Abcb6tm1a(KOMP)Wtsi/Abcb6tm1a(KOMP)Wtsi
(C57BL/6N-Abcb6tm1a(KOMP)Wtsi/Wtsi)
|
abnormal vibrissa morphology
|
J:211773
|
Abcb6tm1Jsch/Abcb6tm1Jsch
(involves: 129)
|
abnormal erythrocyte physiology
|
J:184574
|
abnormal mitochondrial physiology
|
J:184574
|
abnormal stress erythropoiesis
|
J:184574
|
increased physiological sensitivity to xenobiotic
|
J:184574
|
increased sensitivity to xenobiotic induced morbidity/mortality
|
J:184574
|
lethality, incomplete penetrance
|
J:184574
|
Abcb6tm1Pkr/Abcb6tm1Pkr
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:190243
|
Abcb7tm1.1Mdf/Y
(involves: 129S4/SvJae * FVB)
|
prenatal lethality
|
J:106838
|
Abcb7tm1.1Mdf/Abcb7+
(involves: 129S4/SvJae * FVB)
|
genetic imprinting
|
J:106838
|
prenatal lethality
|
J:106838
|
Abcb7tm1Mdf/Y Edil3Tg(Sox2-cre)1Amc/Edil3+
(either: B6.Cg-Edil3Tg(Sox2-cre)1Amc Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA))
|
embryonic lethality between somite formation and embryo turning, complete penetrance
|
J:106838
|
Abcb7tm1Mdf/Y Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(either: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA))
|
abnormal circulating enzyme level
|
J:106838
|
abnormal enzyme/coenzyme activity
|
J:106838
|
abnormal hepatocyte morphology
|
J:106838
|
abnormal liver morphology
|
J:106838
|
hemosiderosis
|
J:106838
|
Abcb7tm1Mdf/Y Tg(Gata1-cre)1Sho/0
(either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) or (involves: 129S4/SvJae * C57BL/6J * FVB/N))
|
abnormal ectoplacental cone morphology
|
J:106838
|
embryonic growth retardation
|
J:106838
|
embryonic lethality between implantation and somite formation, complete penetrance
|
J:106838
|
hemorrhage
|
J:106838
|
Abcb7tm1Mdf/Y Tg(Nes-cre)1Kln/0
(either: B6.Cg-Tg(Nes-cre)1Kln Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL))
|
neonatal lethality, incomplete penetrance
|
J:106838
|
nervous system phenotype
|
J:106838
|
postnatal lethality, complete penetrance
|
J:106838
|
Abcb7tm1Mdf/Y Tg(Vil1-cre)20Syr/0
(either: (involves: 129S4/SvJae * C57BL/6 * DBA/2) or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2))
|
prenatal lethality, complete penetrance
|
J:106838
|
Abcb7tm1Mdf/Abcb7+ Edil3Tg(Sox2-cre)1Amc/Edil3+
(either: B6.Cg-Edil3Tg(Sox2-cre)1Amc Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA))
|
mortality/aging
|
J:106838
|
Abcb7tm1Mdf/Abcb7+ Tg(Gata1-cre)1Sho/0
(either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) or (involves: 129S4/SvJae * C57BL/6J * FVB/N))
|
abnormal ectoplacental cone morphology
|
J:106838
|
embryonic growth retardation
|
J:106838
|
embryonic lethality between implantation and somite formation, complete penetrance
|
J:106838
|
hemorrhage
|
J:106838
|
Abcb7tm1Mdf/Abcb7+ Tg(Vil1-cre)20Syr/0
(either: (involves: 129S4/SvJae * C57BL/6 * DBA/2) or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2))
|
prenatal lethality, complete penetrance
|
J:106838
|
Abcb8tm1Hard/Abcb8tm1Hard A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: FVB)
|
abnormal cardiac muscle relaxation
|
J:182234
|
abnormal cardiovascular system physiology
|
J:182234
|
abnormal heart morphology
|
J:182234
|
abnormal myocardial fiber morphology
|
J:182234
|
cardiac fibrosis
|
J:182234
|
cardiomyopathy
|
J:182234
|
decreased cardiac muscle contractility
|
J:182234
|
decreased cardiac output
|
J:182234
|
decreased left ventricle systolic pressure
|
J:182234
|
increased heart iron level
|
J:182234
|
increased heart left ventricle size
|
J:182234
|
increased heart weight
|
J:182234
|
Abcb9tm1b(KOMP)Wtsi/Abcb9tm1b(KOMP)Wtsi
(C57BL/6N-Abcb9tm1b(KOMP)Wtsi/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
decreased prepulse inhibition
|
J:211773
|
enlarged lymph nodes
|
J:211773
|
increased grip strength
|
J:211773
|
increased hematocrit
|
J:211773
|
small adrenal glands
|
J:211773
|
Abcb10tm1.1Tafu/Abcb10tm1.2Tafu Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6NCrlj * CBA/J * CBA/JNCrlJ)
|
abnormal erythropoiesis
|
J:223428
|
abnormal hemoglobin
|
J:223428
|
abnormal iron level
|
J:223428
|
abnormal mitochondrial morphology
|
J:223428
|
decreased erythrocyte cell number
|
J:223428
|
decreased hemoglobin content
|
J:223428
|
decreased mean corpuscular hemoglobin concentration
|
J:223428
|
decreased mean corpuscular volume
|
J:223428
|
hypochromic microcytic anemia
|
J:223428
|
reticulocytosis
|
J:223428
|
Abcb10tm1.2Tafu/Abcb10tm1.2Tafu
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal blood cell morphology
|
J:223428
|
abnormal embryonic hematopoiesis
|
J:223428
|
abnormal hemoglobin
|
J:223428
|
abnormal hepatocyte morphology
|
J:223428
|
abnormal iron level
|
J:223428
|
abnormal liver morphology
|
J:223428
|
abnormal liver physiology
|
J:223428
|
embryonic lethality during organogenesis, complete penetrance
|
J:223428
|
oxidative stress
|
J:223428
|
pallor
|
J:223428
|
Abcb10tm1Lex/Abcb10+
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal mitochondrial physiology
|
J:189396
|
cardiovascular system phenotype
|
J:189396
|
decreased systemic arterial systolic blood pressure
|
J:189396
|
increased response of heart to induced stress
|
J:189396
|
increased systemic arterial diastolic blood pressure
|
J:189396
|
oxidative stress
|
J:189396
|
Abcb10tm1Lex/Abcb10tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
|
embryonic lethality, complete penetrance
|
J:189396
|
Abcb11tm1a(EUCOMM)Hmgu/Abcb11tm1a(EUCOMM)Hmgu
(C57BL/6N-Abcb11tm1a(EUCOMM)Hmgu/Ieg)
|
abnormal retina morphology
|
J:165965
|
increased circulating alanine transaminase level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating aspartate transaminase level
|
J:165965
|
increased circulating potassium level
|
J:165965
|
increased lean body mass
|
J:165965
|
Abcb11tm1b(EUCOMM)Hmgu/Abcb11+
(C57BL/6N-Abcb11tm1b(EUCOMM)Hmgu/Ieg)
|
abnormal lung morphology
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
decreased locomotor activity
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Abcb11tm1b(EUCOMM)Hmgu/Abcb11tm1b(EUCOMM)Hmgu
(C57BL/6N-Abcb11tm1b(EUCOMM)Hmgu/Ieg)
|
preweaning lethality, incomplete penetrance
|
J:211773
|
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal bile canaliculus morphology
|
J:67548
|
abnormal bile salt level
|
J:67548
|
abnormal bile secretion
|
J:67548
|
abnormal hepatocyte morphology
|
J:67548
|
abnormal phospholipid level
|
J:67548
|
decreased body weight
|
J:67548
|
decreased liver glycogen level
|
J:67548
|
enlarged liver
|
J:67548
|
increased bile salt level
|
J:67548
|
increased cholesterol level
|
J:67548
|
intrahepatic cholestasis
|
J:67548
|
postnatal growth retardation
|
J:67548
|
Abcc1tm1Acs/Abcc1tm1Acs
(involves: 129S1/Sv * C57BL/6)
|
abnormal homeostasis
|
J:44305
|
hematopoietic system phenotype
|
J:44305
|
increased physiological sensitivity to xenobiotic
|
J:44305
|
Abcc1tm1Bor/Abcc1tm1Bor
(involves: 129P2/OlaHsd * FVB)
|
abnormal mast cell physiology
|
J:44110
|
decreased inflammatory response
|
J:44110
|
increased physiological sensitivity to xenobiotic
|
J:44110
|
increased sensitivity to xenobiotic induced morbidity/mortality
|
J:44110
|
mortality/aging
|
J:44110
|
Abcc1tm1Bor/Abcc1tm1Bor Tg(Thy1-AppDutch)#Jckr/0
(FVB.Cg-Abcc1tm1Bor Tg(Thy1-AppDutch)#Jckr)
|
abnormal homeostasis
|
J:178230
|
amyloid beta deposits
|
J:178230
|
Abcc1tm1Bor/Abcc1tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0
(FVB.Cg-Abcc1tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
|
amyloid beta deposits
|
J:178230
|
microgliosis
|
J:178230
|
Abcc2tm1.1(ABCC2)Arte/Abcc2tm1.1(ABCC2)Arte
(C57BL/6-Abcc2tm1.1(ABCC2)Arte)
|
homeostasis/metabolism phenotype
|
J:208127
|
Abcc2tm1.1(ABCC2)Arte/Abcc2tm1.1(ABCC2)Arte Nr1i2tm1(NR1I2)Arte/Nr1i2tm1(NR1I2)Arte
(involves: C57BL/6)
|
homeostasis/metabolism phenotype
|
J:216646
|
Abcc2tm1Ahs/Abcc2tm1Ahs
(involves: 129P2/OlaHsd * FVB)
|
abnormal bile secretion
|
J:107822
|
abnormal blood homeostasis
|
J:107822
|
abnormal kidney physiology
|
J:107822
|
abnormal liver physiology
|
J:107822
|
abnormal xenobiotic pharmacokinetics
|
J:107822
|
bilirubinuria
|
J:107822
|
decreased hemoglobin content
|
J:107822
|
increased circulating bilirubin level
|
J:107822
|
increased liver weight
|
J:107822
|
Abcc2tm1Ahs/Abcc2tm1Ahs
(FVB.129P2-Abcc2tm1Ahs)
|
abnormal xenobiotic pharmacokinetics
|
J:107822
|
bilirubinuria
|
J:216646
|
increased circulating bilirubin level
|
J:216646
|
Abcc2tm1Ahs/Abcc2tm1Ahs
(B6.129P2(FVB)-Abcc2tm1Ahs)
|
increased circulating bilirubin level
|
J:208127
|
increased physiological sensitivity to xenobiotic
|
J:208127
|
Abcc2tm1Dgen/Abcc2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal bile composition
|
J:134950
|
abnormal bile secretion
|
J:134950
|
abnormal liver physiology
|
J:134950
|
decreased circulating alkaline phosphatase level
|
J:134950
|
increased circulating bilirubin level
|
J:134950
|
increased circulating cholesterol level
|
J:134950
|
Abcc2tm2b(KOMP)Wtsi/Abcc2tm2b(KOMP)Wtsi
(C57BL/6N-Abcc2tm2b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
decreased mean corpuscular volume
|
J:211773
|
decreased mean platelet volume
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased kidney weight
|
J:211773
|
increased neutrophil cell number
|
J:211773
|
Abcc3tm1Bor/Abcc3tm1Bor
(involves: 129P2/Ola * FVB/N)
|
abnormal bile salt homeostasis
|
J:149653
|
abnormal xenobiotic pharmacokinetics
|
J:99234
|
Abcc3tm1Bor/Abcc3tm1Bor
(FVB.129P2-Abcc3tm1Bor)
|
abnormal xenobiotic pharmacokinetics
|
J:99234
|
decreased chemically-elicited antinociception
|
J:99234
|
Abcc3tm1Kruh/Abcc3tm1Kruh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal bile salt level
|
J:114229
|
increased circulating bilirubin level
|
J:114229
|
liver/biliary system phenotype
|
J:114229
|
Abcc3tm1Kruh/Abcc3tm1Kruh Slc51atm1Pda/Slc51atm1Pda
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal bile salt homeostasis
|
J:132778
|
Abcc4Gt(RRC212)Byg/Abcc4Gt(RRC212)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:139829
|
increased chemical nociceptive threshold
|
J:139829
|
increased thermal nociceptive threshold
|
J:139829
|
Abcc4tm1Jsch/Abcc4tm1Jsch
(involves: 129X1/SvJ)
|
abnormal blood-brain barrier function
|
J:92788
|
abnormal blood-cerebrospinal fluid barrier function
|
J:92788
|
abnormal urine organic anion level
|
J:92788
|
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
|
abnormal blood homeostasis
|
J:117326
|
abnormal blood-brain barrier function
|
J:117326
|
abnormal intestinal mucosa morphology
|
J:117326
|
abnormal small intestine morphology
|
J:117326
|
abnormal spleen B cell follicle morphology
|
J:117326
|
abnormal spleen red pulp morphology
|
J:117326
|
increased sensitivity to induced morbidity/mortality
|
J:117326
|
increased susceptibility to induced colitis
|
J:117326
|
intestinal inflammation
|
J:117326
|
small intestinal inflammation
|
J:117326
|
small spleen
|
J:117326
|
thymus cortex hypoplasia
|
J:117326
|
weight loss
|
J:117326
|
Abcc5em1(IMPC)H/Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased eosinophil cell number
|
J:211773
|
decreased leukocyte cell number
|
J:211773
|
decreased lymphocyte cell number
|
J:211773
|
impaired glucose tolerance
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased startle reflex
|
J:211773
|
limb grasping
|
J:211773
|
Abcc5tm1Bor/Abcc5tm1Bor
(involves: 129P2/OlaHsd * FVB)
|
cellular phenotype
|
J:135561
|
Abcc6Dyscalc1-C3H/DiSnA/Abcc6Dyscalc1-C57BL/10
(involves: C3H/DiSnA * C57BL/10)
|
decreased susceptibility to dystrophic cardiac calcinosis
|
J:76777
|
Abcc6Dyscalc1-C3H/HeNCrl/Abcc6Dyscalc1-C3H/HeNCrl
(involves: C3H/HeNCrl * C57BL/6NCrl)
|
increased susceptibility to dystrophic cardiac calcinosis
|
J:109580
|
Abcc6Dyscalc1-C57BL/6J/Abcc6Dyscalc1-C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased susceptibility to dystrophic cardiac calcinosis
|
J:72021
|
Abcc6Dyscalc1-C57BL/10/Abcc6Dyscalc1-C57BL/10
(involves: C3H/DiSnA * C57BL/10)
|
decreased susceptibility to dystrophic cardiac calcinosis
|
J:76777
|
Abcc6Dyscalc1-DBA/2J/Abcc6Dyscalc1-DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to dystrophic cardiac calcinosis
|
J:76777
|
Abcc6rs32756904-T/Abcc6Dyscalc1-C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased susceptibility to dystrophic cardiac calcinosis
|
J:72021
|
Abcc6rs32756904-T/Abcc6rs32756904-T
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to dystrophic cardiac calcinosis
|
J:72021,
J:33253
|
Abcc6rs32756904-T/Abcc6rs32756904-T Dyscalc2C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to dystrophic cardiac calcinosis
|
J:72021
|
Abcc6tm1Aabb/Abcc6tm1Aabb
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal Bruch membrane morphology
|
J:105062
|
abnormal kidney blood vessel morphology
|
J:105062
|
calcified artery
|
J:105062
|
calcified skin
|
J:105062
|
decreased circulating HDL cholesterol level
|
J:105062
|
increased circulating creatinine level
|
J:105062
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi E2f1Tg(Wnt1-cre)2Sor/?
(B6.Cg-E2f1Tg(Wnt1-cre)2Sor Abcc6tm1c(EUCOMM)Wtsi)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi E2f1Tg(Wnt1-cre)2Sor/? Speer6-ps1Tg(Alb-cre)21Mgn/?
(B6.Cg-E2f1Tg(Wnt1-cre)2Sor Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Pax7tm1(cre)Mrc/?
(B6.Cg-Pax7tm1(cre)Mrc Abcc6tm1c(EUCOMM)Wtsi)
|
integument phenotype
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Ptprctm1(cre)Medv/?
(B6.Cg-Ptprctm1(cre)Medv Abcc6tm1c(EUCOMM)Wtsi)
|
integument phenotype
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/?
(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/? Tg(Cdx1-cre)23Kem/?
(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn Tg(Cdx1-cre)23Kem)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Tg(Cdh5-cre)7Mlia/?
(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Cdh5-cre)7Mlia)
|
integument phenotype
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Tg(Cdh16-cre)91Igr/?
(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Cdh16-cre)91Igr)
|
integument phenotype
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Tg(CMV-cre)1Cgn/?
(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(CMV-cre)1Cgn)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Tg(Fabp4-cre)1Rev/?
(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Fabp4-cre)1Rev)
|
integument phenotype
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Tg(Pdgfrb-cre)35Vli/?
(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Pdgfrb-cre)35Vli)
|
integument phenotype
|
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi Tg(Tagln-cre)1Her/?
(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Tagln-cre)1Her)
|
integument phenotype
|
J:252837
|
Abcc6tm1Jfk/Abcc6tm1Jfk
(involves: 129S1/Sv * C57BL/6J)
|
abnormal vibrissa follicle morphology
|
J:101372
|
calcified artery
|
J:101372
|
calcified retina
|
J:101372
|
calcified skin
|
J:101372
|
calcinosis
|
J:101372
|
nephrocalcinosis
|
J:101372
|
Abcc6tm1Jfk/Abcc6tm1Jfk
(B6.129S1-Abcc6tm1Jfk)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1Jfk/Abcc6tm1Jfk Enpp1asj/Enpp1+
(B6.Cg-Abcc6tm1Jfk Enpp1asj)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1Jfk/Abcc6tm1Jfk Enpp1asj/Enpp1asj
(B6.Cg-Abcc6tm1Jfk Enpp1asj)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1Jfk/Abcc6tm1Jfk Nt5etm1Lft/Nt5etm1Lft
(B6.Cg-Abcc6tm1Jfk Nt5etm1Lft)
|
abnormal snout skin morphology
|
J:252837
|
calcified skin
|
J:252837
|
calcinosis
|
J:252837
|
Abcc6tm1Jfk/Abcc6tm1Jfk Samd9ltm1Homy/Samd9ltm1Homy
(B6.129-Samd9ltm1Homy Abcc6tm1Jfk)
|
abnormal vibrissa morphology
|
J:225110
|
calcinosis
|
J:225110
|
Abcc8em1(IMPC)J/Abcc8em1(IMPC)J
(C57BL/6NJ-Abcc8em1(IMPC)J/Mmjax)
|
impaired glucose tolerance
|
J:211773
|
Abcc8tm1.1Fmas/Abcc8+
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
abnormal pancreatic beta cell morphology
|
J:208932
|
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
abnormal pancreatic beta cell morphology
|
J:208932
|
decreased circulating glucose level
|
J:208932
|
decreased insulin secretion
|
J:208932
|
homeostasis/metabolism phenotype
|
J:208932
|
impaired glucose tolerance
|
J:208932
|
increased circulating glucose level
|
J:208932
|
increased insulin secretion
|
J:208932
|
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn
(involves: 129X1/SvJ * C57BL/6)
|
decreased insulin secretion
|
J:79352
|
hypoglycemia
|
J:79352
|
impaired glucose tolerance
|
J:79352
|
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn Abcc9em3Nich/Abcc9em3Nich
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal myocardial fiber currents
|
J:308986
|
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ * C57BL/6)
|
hypoglycemia
|
J:61356
|
impaired glucose tolerance
|
J:61356
|
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ)
|
abnormal insulin secretion
|
J:179577
|
decreased circulating glucose level
|
J:179577
|
decreased insulin secretion
|
J:179577
|
increased circulating glucose level
|
J:179577
|
Abcc8tm1Jbry/Abcc8tm1Jbry Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129X1/SvJ)
|
abnormal insulin secretion
|
J:179577
|
decreased circulating glucose level
|
J:179577
|
decreased insulin secretion
|
J:179577
|
increased circulating glucose level
|
J:179577
|
Abcc8tm1Mgn/Abcc8+
(involves: 129X1/SvJ)
|
no phenotypic analysis
|
J:79352
|
Abcc9em1(IMPC)H/Abcc9+
(C57BL/6N-Abcc9em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
increased monocyte cell number
|
J:211773
|
Abcc9em1Nich/Abcc9+
(involves: C57BL/6J * CBA/J)
|
abnormal blood vessel physiology
|
J:281903
|
abnormal channel response
|
J:281903
|
abnormal heart echocardiography feature
|
J:281903
|
abnormal thoracic aorta morphology
|
J:281903
|
abnormal vascular smooth muscle physiology
|
J:281903
|
aortic arch dilation
|
J:281903
|
cardiac hypertrophy
|
J:281903
|
decreased survivor rate
|
J:281903
|
dilated heart left ventricle
|
J:281903
|
enlarged heart
|
J:281903
|
hypotension
|
J:281903
|
increased cardiac output
|
J:281903
|
increased cardiac stroke volume
|
J:281903
|
increased heart weight
|
J:281903
|
increased vasodilation
|
J:281903
|
premature death
|
J:281903
|
Abcc9em1Nich/Abcc9+ Kcnj8em1Nich/Kcnj8+
(involves: C57BL/6J * CBA/J)
|
premature death
|
J:281903
|
Abcc9em1Nich/Abcc9em1Nich
(involves: C57BL/6J * CBA/J)
|
abnormal channel response
|
J:281903
|
abnormal heart echocardiography feature
|
J:281903
|
abnormal vascular smooth muscle physiology
|
J:281903
|
aortic valve regurgitation
|
J:281903
|
cardiac hypertrophy
|
J:281903
|
decreased survivor rate
|
J:281903
|
dilated heart left ventricle
|
J:281903
|
enlarged heart
|
J:281903
|
hypotension
|
J:281903
|
increased cardiac output
|
J:281903
|
increased cardiac stroke volume
|
J:281903
|
increased heart weight
|
J:281903
|
premature death
|
J:281903
|
Abcc9em2Nich/Abcc9em2Nich
(involves: C57BL/6J * CBA/J)
|
abnormal channel response
|
J:281630
|
abnormal heart echocardiography feature
|
J:281630
|
behavior/neurological phenotype
|
J:281630
|
decreased cardiac muscle contractility
|
J:281630
|
dilated heart left ventricle
|
J:281630
|
increased muscle fatigability
|
J:281630
|
increased systemic arterial blood pressure
|
J:281630
|
Abcc9em3Nich/Abcc9+
(B6.Cg-Abcc9em3Nich)
|
abnormal myocardial fiber currents
|
J:308986
|
abnormal myocardial fiber morphology
|
J:308986
|
cardiovascular system phenotype
|
J:308986
|
dilated aorta
|
J:308986
|
dilated heart
|
J:308986
|
enlarged heart
|
J:308986
|
Abcc9em3Nich/Abcc9em3Nich
(B6.Cg-Abcc9em3Nich)
|
abnormal aorta smooth muscle morphology
|
J:308986
|
abnormal impulse conducting system conduction
|
J:308986
|
abnormal myocardial fiber currents
|
J:308986
|
abnormal myocardial fiber morphology
|
J:308986
|
abnormal physiological response to xenobiotic
|
J:308986
|
cardiovascular system phenotype
|
J:308986
|
dilated aorta
|
J:308986
|
dilated heart
|
J:308986
|
enlarged heart
|
J:308986
|
Abcc9tm1.1Mcn/Abcc9tm1.1Mcn Tg(Tagln-cre)1Her/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal fetal cardiomyocyte morphology
|
J:216539
|
abnormal fetal cardiomyocyte physiology
|
J:216539
|
abnormal mitochondrial morphology
|
J:216539
|
abnormal mitochondrial physiology
|
J:216539
|
cardiomyopathy
|
J:216539
|
decreased cardiac muscle contractility
|
J:216539
|
decreased fatty acid oxidation
|
J:216539
|
decreased mitochondrial size
|
J:216539
|
decreased oxygen consumption
|
J:216539
|
enlarged heart
|
J:216539
|
homeostasis/metabolism phenotype
|
J:216539
|
hypoxia
|
J:216539
|
increased cellular sensitivity to hydrogen peroxide
|
J:216539
|